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The	 mechanisms	 that	 govern	 the	 lineage	 commitment	 of	 haematopoietic	 stem	 and	
progenitor	cells	(HSPCs)	have	been	a	topic	of	debate	since	the	1960s.	Two	models	of	lineage	
commitment	have	been	described;	 a	 permissive	model,	 in	which	haematopoietic	 growth	
factors	(HGFs)	stimulate	proliferation	and	survival	of	distinct	HSPC	subpopulations	to	permit	
stochastic	 lineage-specification,	 and	 a	 deterministic	 model	 which	 proposes	 that	 HGFs	
instruct	HSPCs	to	differentiate	towards	a	specific	cell	lineage.	To	provide	further	insight	into	
whether	 HGFs	 provide	 instructive	 cues	 or	 act	 in	 a	 selective	 manner,	 this	 study	 has	

























































































































































































































































































































































































































































The	 formation	 of	 blood	 and	 immune	 cells	 in	 adult	 mammals	 is	 a	 complex	 and	 tightly	
regulated	 system	 controlled	 by	 the	 self-renewal	 and	 differentiation	 of	 rare	 quiescent	
haematopoietic	stem	cells	(HSCs)	that	reside	within	the	bone	marrow	(BM).	HSCs	are	at	the	
apex	of	the	haematopoietic	hierarchy,	and	have	the	ability	to	self-renew	and	differentiate	to	
maintain	 the	 haematopoietic	 system.	 As	 HSCs	 mature,	 they	 give	 rise	 to	 multipotent	
progenitors	(MPPs),	which	are	more	proliferative	than	HSCs	and	lack	long-term	self-renewal	
capacity.	MPPs	 then	 differentiate	 to	 give	 rise	 to	 functional	 cell	 types	 via	 progenitor	 cell	
intermediates.	These	terminally	differentiated	cells	are	typically	divided	into	the	lymphoid	




comprised	 of	 T-lymphocytes,	 B-lymphocytes	 and	 natural	 killer	 (NK)	 lymphocytes	 [1].	 T-
lymphocytes,	which	mature	in	the	thymus,	are	mainly	involved	in	cell-mediated	immunity,	
and	 can	be	divided	 into	 a	 number	 of	 subfamilies	 that	 are	 responsible	 for	 immunological	
memory,	 cell-mediated	 cytotoxicity	 and	 regulating	 the	 immune	 response.	 B-lymphocytes	
mature	 in	the	BM	and	are	classically	 involved	 in	regulating	 immune	function	via	humoral	





The	myeloid	 family	 includes	monocytes/macrophages,	 granulocytes,	megakaryocytes	 and	
erythrocytes	[1].	Monocytes,	which	are	precursors	to	macrophages,	circulate	in	the	blood	
and	play	an	important	role	in	both	homeostasis	and	inflammation.	Following	inflammation,	
monocytes	 migrate	 to	 target	 tissues	 and	 differentiate	 into	 macrophages	 which	 act	 as	
phagocytes	and	professional	antigen	presenting	cells	(AgPCs)	[1].	Under	normal	physiological	
conditions,	tissue-resident	macrophages	perform	general	and	tissue-specific	functions,	such	











Megakaryocytes	 are	 large	 BM-resident	 cells	 that	 undergo	 fragmentation	 of	 their	 plasma	
membrane	 and	 cytoplasm	 to	 generate	 thrombocytes	 (platelets),	 which	 contribute	 to	
haemostasis:	a	process	that	prevents	bleeding	following	vessel	injury	[4].	Erythrocytes,	are	






















1.1			The	 nature	 of	 early	 haematopoietic	 stem	 and	
progenitor	cells	in	the	adult	
	
Advancements	 in	 cell	 isolation	 techniques	 have	 facilitated	 the	 purification	 of	 highly	
homogeneous	murine	HSPC	populations	based	on	the	expression	of	a	range	of	cell	surface	




they	 begin	 to	 differentiate	 and	 acquire	 lineage	 associated	 cell	 surface	 markers	 (Lin),	
including;	 B220,	 which	 is	 present	 on	 B-lymphocytes	 [12];	 CD3,	 a	 marker	 for	 mature	 T-
lymphocytes	[13];	CD11b	and	Gr-1,	mature	DC	and	myeloid	cell	markers	[14,	15];	and	TER-
119,	 which	 is	 expressed	 by	 erythroid	 cells	 [16].	 As	 such,	 virtually	 all	 of	 the	multilineage	
potential	of	the	BM	resides	within	the	Lin−	Sca1+	c-Kit+	(LSK)	compartment.		
	







reconstitution	 [17].	 Long-term	 repopulating	 HSCs	 (LT-HSCs)	 are	 defined	 as	 cells	 that	 are	
capable	of	multilineage	reconstitution	in	primary	irradiated	recipients	for	at	least	six	months,	
and	 can	 subsequently	 repopulate	 a	 secondary	 irradiated	 recipient	 [18].	 Short-term	
repopulating	 HSCs	 (ST-HSCs)	 are	 considered	 to	 possess	 multilineage	 potential,	 and	
reconstitute	the	haematopoietic	system	in	an	irradiated	host	for	8-12	weeks	[19,	20].	Finally,	
MPPs	 have	 very	 little	 self-renewal	 ability,	 and	 are	 only	 capable	 of	 transient	multilineage	
engraftment	when	transferred	 into	primary	 irradiated	hosts	[21,	22].	 Interestingly,	recent	
studies	have	shown	that	not	all	long-term	repopulating	cells	in	the	mouse	and	human	are	







Figure	 1.1.	 Progression	 of	 the	models	 used	 to	 identify	HSPCs	 in	 the	 adult	mouse	 bone	
marrow.	 Cell	 surface	 antigens	 are	used	 to	distinguish	 LT-HSCs,	 ST-HSCs,	 and	MPPs.	 Early	





early	 HSPCs	 using	 the	 signalling	 lymphocytic	 activation	molecule	 family	markers;	 CD150,	
CD48,	and	CD244	[22].	In	2013,	the	Morison	group	added	CD299	to	their	staining	strategy	to	
distinguish	myeloid-biased	HSC-1	and	lymphoid-biased	HSC-2	subpopulations,	which	share	
characteristics	 with	 LT-HSCs	 and	 ST-HSCs,	 respectively.	 They	 also	 identified	 three	 MPP	
subpopulations	[34].	HSPCs,	haematopoietic	stem	and	progenitor	cells;	LT-HSC,	 long-term	
haematopoietic	stem	cell;	ST-HSC,	short-term	haematopoietic	stem	cell;	MPP,	multipotent	
progenitor;	 LSK,	 lineage	 associated	 surface	markers−,	 Sca1+,	 c-Kit+;	 Flt3,	 fms-like	 tyrosine	
kinase	3.	
	




























































































be	 absent	 from	 the	 surface	 of	 LT-HSCs	 [37,	 38],	 in	 combination	 with	 the	 LSK	












workers	 to	 characterise	 the	 HSC-1	 and	 HSC-2	 populations	 [34].	 The	 CD229−	 HSC-1	 are	
myeloid-biased	 (MyHSCs)	and	 rarely	divide,	while	 the	CD229+	HSC-2	are	 lymphoid-biased	






While	 HSC	 isolation	 strategies	 have	 primarily	 relied	 on	 the	 use	 of	 cell	 surface	 markers,	
Wiessman’s	 group	 has	 recently	 identified	 the	 transcription	 factor	 (TF)	 Hoxb5	 as	 a	 highly	
specific	marker	of	 LT-HSCs	 [39].	Chen	et	al.	used	a	Hoxb5:tri-mCherry	 reporter	 system	to	
show	that	high	 levels	of	Hoxb5	strongly	correlated	with	 long-term	repopulating	potential	





Human	 HSCs	 (hHSCs)	 are	 not	 as	 well	 characterised	 as	 their	 mouse	 counterparts,	 and	 a	
number	of	immunophenotypes	have	been	described	for	their	isolation.	hHSCs	are	commonly	
identified	in	vitro	using	long-term	culture-initiating	cell	(LTC-IC)	assays,	which	use	BM	stromal	
co-culture	 systems	 to	provide	quantitative	assessment	of	haematopoietic	 cell	 production	
over	 time	 [40].	 Another,	 more	 recent,	 method	 for	 characterising	 hHSCs	 is	 the	 use	 of	
xenograft	assays.	These	assays	 involve	the	xenotransplantation	of	human	haematopoietic	











CD34	 expression	 on	 human	 HSPCs	 is	 reversible,	 as	 CD34+	 cells	 capable	 of	 long-term	
multilineage	engraftment	can	give	 rise	 to	CD34−	cells	and	vice	versa	 [53,	55-57].	 In	2011,	
Notta	 and	 co-workers	 identified	 CD49f	 as	 a	 highly	 specific	 marker	 for	 hHSCs,	 and	
demonstrated	 that	 single	 CD49f+	 adult	 BM	 cells	 were	 capable	 of	 long-term	multilineage	
engraftment	 [58].	 Other	 markers	 that	 have	 been	 proposed	 to	 enrich	 for	 hHSCs	 include	
AC133,	HLA-DR,	Thy1	and	CD45R	[58-65].	
	




lymphoid	 and	myeloid	 lineages	 (Figure	 1.2A).	 The	model	 proposes	 that	 as	HSCs	mature,	
there	 is	a	point	 in	 their	development	whereby	 they	 irreversibly	 commit	 towards	either	a	
lymphoid	 or	myeloid	 fate.	 In	 this	model,	 there	 are	 only	 single	 ‘routes’	 of	 differentiation	
towards	 cells	 of	 a	 particular	 fate,	 suggesting	 a	 rigid	 haematopoietic	 architecture.	 The	
myeloid-lymphoid	dichotomy	model	was	proposed	by	 the	Weissman	group	 following	 the	
isolation	of	two	progenitors	in	the	adult	mouse	BM.	In	1997,	Kondo	et	al.	described	a	Lin−	
Sca1lo	 c-Kitlo	 Thy1−	 IL-7R+	 BM	 cell	 which	 could	 rapidly	 generate	 T-lymphocytes	 and	 B-
lymphocytes	when	transplanted	into	an	irradiated	host	[66].	As	the	authors	did	not	detect	
significant	myeloid	potential	during	 these	experiments,	 the	cell	was	 termed	the	common	
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[67],	 the	 Weissman	 group	 proposed	 a	 myeloid-lymphoid	 dichotomy	 model	 of	
haematopoiesis	whereby	HSCs	irreversibly	commit	towards	either	the	lymphoid	or	myeloid	
lineage	during	the	early	stages	of	maturation.	(B)	The	Katsura	group	has	used	fetal	thymic	
cultures	 to	 describe	 a	myeloid-based	model	 of	 haematopoiesis	 in	which	GM	potential	 is	
maintained	as	a	default	during	HSPC	differentiation	towards	erythroid,	B-lymphocyte	and	T-
lymphocyte	cell	fates	[68-72].	(C)	depicts	a	model	proposed	by	the	Jacobsen	group	following	
the	 characterisation	 of	 the	 LMPP	 [73].	 HSC,	 haematopoietic	 stem	 cell;	 CMP,	 common	

















cells	were	 commonly	 observed	 together.	 However,	 the	 authors	 never	 observed	 colonies	
containing	 T-lymphocytes	 and	 B-lymphocytes	 without	 GM	 cells.	 Using	 a	 similar	 in	 vitro	




model,	 GM	 potential	 is	 retained	 as	 HSPCs	 differentiate	 towards	 the	 T-lymphocyte,	 B-
lymphocyte	and	erythroid	lineages.	GM	potential	is	only	lost	during	the	final	stages	of	the	T-









GM	 potential	 [73].	 The	 authors	 noted	 that	 these	 cells	 generated	 few	 erythrocytes	 and	
megakaryocytes	 both	 in	 vitro	 and	 in	 vivo,	 and	 proposed	 a	 new	model	 in	which	 the	 first	
commitment	 decision	made	 during	 haematopoiesis	 results	 in	 either	 loss	 of	 lymphoid	 or	
MegE	potential	(Figure	1.2C).	Subsequently,	the	Rolink	group	described	another	progenitor	
cell	with	similar	potential	to	the	LMPP	[75,	76].	This	cell,	termed	the	early	progenitor	with	
lymphoid	 and	 myeloid	 potential,	 has	 the	 ability	 to	 differentiate	 into	 lymphocytes	 and	
macrophage/monocytes	in	vitro,	and	gives	rise	to	B-lymphocytes	and	T-lymphocytes	in	vivo	








termed	 the	 pairwise	 relationship	 model,	 proposes	 that	 as	 HSCs	 differentiate	 towards	 a	
specific	cell	fate,	fates	that	are	the	least	related	to	this	dominant	cell	type	become	latent	
first,	while	more	closely	related	fates	persist	as	possible,	but	less	preferred,	potentials.	The	















lineage-branching.	 The	 inner	 arcs	 depict	 the	 maturation	 potential	 of	 haematopoietic	
progenitors.	Both	CMPs	and	CLPs	can	give	rise	to	DCs	[8],	as	depicted	by	the	arrowheads.	
Modified	 from	 [78]	 ©	 Macmillan	 Magazines	 Ltd.	 HSC,	 haematopoietic	 stem	 cell;	 DC,	
dendritic	cell;	CMP,	common	myeloid	progenitor;	CLP,	common	lymphoid	progenitor;	LMPP,	




that	 are	 placed	 adjacent	 to	 each	 other	 have	 been	 shown	 to	 share	 similar	 TF	 expression	
patterns	 [78,	79].	Additionally,	 this	arrangement	of	 cell	 lineages	 is	also	 supported	by	 the	



















Lastly,	 a	 monocyte-B-lymphocyte	 bipotent	 progenitor	 has	 been	 described,	 but	 the	 DC	








maturation	 potentials	 [66,	 75,	 76].	 As	 described	 for	 Figure	 1.3,	 each	 arc	 represents	 the	
lineage	potential	of	a	given	cell.	Again,	cells	can	only	mature	along	a	path	that	does	not	result	
in	a	gain	of	 lineage	potential.	 The	CMP	cannot	give	 rise	 to	a	CLP	or	EPLM,	as	 this	would	
require	the	resoration	of	lymphoid	potential.	However,	it	can	give	rise	to	GMPs	and	MEPs.	
The	 figure	 depicts	 multiple	 paths	 of	 differentiation	 to	 end	 cell	 types	 and	 forgoes	 the	
restrictive	 nature	 of	 past	models.	 For	 example,	 neutrophils	 can	 be	 generated	 from	both	
CMPs	and	LMPPs	(Figure	1.5)	[67,	73].	Similarly,	Ishikawa	et	al.	have	shown	that	CLP-	and	








myeloid	 potential	 [75];	MEP,	megakaryocyte-erythroid	 progenitor	 [67];	GMP,	 granulocyte-macrophage	 progenitor	 [67];	 DC/Pro-B,	 dendritic	
cell/B-lymphocyte	progenitor	[85];	Mon/B/DC?,	monocyte/B-lymphocyte	progenitor	(dendritic	cell	potential	has	not	been	assessed)	[83,	84,	86];	
























debate	since	 the	1960s.	 In	 the	case	of	haematopoiesis,	various	aspects	of	 the	behavior	of	
















group	 performed	 serial	 transplantation	 experiments	 and	 examined	 the	 number	 of	 CFUs	
within	spleen	colonies	[89].	Ten	days	post-transplantation,	Till	et	al.	prepared	cell	suspensions	
from	 individual	 spleen	 colonies	 from	 the	 recipient	 mice,	 performed	 a	 second	 set	 of	
	 17	
transplantation	 experiments,	 and	 counted	 the	 number	 of	 spleen	 colonies	 in	 secondary	
recipients	after	10-14	days.	As	to	the	spleen	colonies	observed	in	the	secondary	recipients,	
the	 number	 present	 in	 each	 mouse	 was	 not	 uniform.	 The	 data	 obtained	 followed	 a	 γ-
distribution,	and	Till	et	al.	concluded	that	the	distribution	of	spleen	colony	forming	units	(CFU-
S)	 within	 each	 of	 the	 spleen	 colonies	 was	 variable	 [89].	 	 The	 group	 proposed	 that	 the	
frequency	of	CFU-S	within	an	individual	spleen	colony	was	due	to	a	‘birth	and	death’	process.	
Using	 a	 Monto	 Carlo	 method	 [91],	 a	 mathematical	 equation,	 the	 authors	 concluded	 the	
process	 in	 which	 CFU-S	 undergo	 self-renewal	 (birth)	 and	 differentiation	 (or	 death)	 was	
stochastic.	In	1973,	the	Till	group	provided	further	evidence	to	support	the	notion	that	the	
self-renewal	and	differentiation	of	CFU-S	is	a	stochastic	process.	Using	the	same	approach	as	
before	 [89],	 	 they	 examined	 the	 differentiation	 of	 CFU-S	 towards	 the	 erythroid	 and	






from	 a	 primary	 BM-derived	 cell	 line	 were	 seeded	 into	methylcellulose	 cultures	 [93].	 The	
number	of	CFUs	in	each	of	the	secondary	colonies	were	found	to	be	heterogeneous	in	their	













Later	 work	 by	 Abkowitz	 et	 al.	 examined	 the	 extent	 to	 which	 clones	 of	 individual	 HSCs	
contribute	to	haematopoiesis	[97].	Safari	cats	were	used,	which	possess	two	distinct	X-linked	











Hence,	 the	 results	 suggest	 that	 the	manner	 in	which	 an	 individual	 HSC	 does	 or	 does	 not	
contribute	 to	 steady-state	 haematopoiesis	 at	 any	 given	 time	 is	 governed	 by	 a	 stochastic	









variable	 and	 to	 change	 over	 time.	 As	 before,	 the	 group	 accurately	 reproduced	 the	












CFU-E	and	BFU-E	were	quantified	during	 the	 recovery	phase	using	 in	vitro	colony	 forming	
assays,	and	the	findings	were	compared	to	a	stochastic	computer	simulation	whereby	single	
cells	from	each	cell	type	either	underwent	self-renewal,	differentiation	or	death	at	random.	
The	 authors	 concluded	 that	 emergency	 erythropoiesis	 can	 be	 explained	 by	 a	 stochastic	
process	 and	 that	 the	probability	of	BFU-E	and	CFU-E	 replicating	during	 stress	 is	 increased	
when	compared	to	steady	state	haematopoiesis.	
	 20	
1.3.1.2			Stochastic	 lineage	 commitment	 of	 haematopoietic	 stem	 and	
progenitor	cells	
	





by	 a	 stochastic	 process	 [101].	 To	 test	 this	 theory,	 Ogawa’s	 group	 undertook	 in	 vitro	
experiments	to	analyse	the	commitment	of	HSPCs	towards	a	specific	lineage	[102,	103].	In	
their	 first	study,	Suda	et	al.	 isolated	single	cells	 from	primary	blast	cell	colonies	 (prepared	
from	 suspensions	 of	 mouse	 spleen	 cells)	 and	 performed	 methylcellulose	 colony	 forming	
assays	to	determine	their	patterns	of	lineage	commitment	[102].	The	authors	noted	that	the	




















same	conclusion.	 In	1984,	Leary	and	co-workers	prepared	blast	colonies	 from	either	 fresh	
human	cord	blood	or	BM,	and	used	 individual	 cells	 from	 these	blast	 colonies	 to	generate	




cell	 from	 the	 same	 blast	 colony	 generated	 a	 secondary	 colony	 which	 contained	 180	
neutrophils	and	macrophages.	A	year	later,	Leary	and	co-workers	used	a	similar	approach	to	
generate	 paired	 daughter	 cells	 from	My-10+	 cord	 blood-derived	 blast	 colonies	 [105].	 The	
group	 successfully	 generated	 colonies	 from	75	pairs	 of	 daughter	 cells.	When	 the	 colonies	
were	characterised,	forty	of	these	pairs	were	shown	to	generate	homologous	colonies,	while	
the	 other	 35	 pairs	 generated	 non-homologous	 colonies.	 Though	 the	 homologous	 paired	
colonies	displayed	similar	lineage	compositions,	the	colony	size	and	number	of	cells	from	each	






cell-intrinsic	 factors	 that	 occur	 through	 stochastic	 gene	 expression	 and	 competitive	
interactions	between	TFs,	which	eventually	result	 in	the	manifestations	of	specific	 lineage-
associated	transcriptional	programs.	These	 lineage-associated	programs	are	then	enforced	
through	 positive	 feedback	 mechanisms,	 leading	 to	 commitment	 of	 the	 cell	 towards	 a	





of	 multipotent	 haematopoietic	 cells	 made	 use	 of	 haematopoietic	 cell	 lines.	 In	 particular,	
factor-dependent	 cell	 Paterson	 (FDCP)-mix	 cell	 lines	have	been	 indispensable	due	 to	 their	
extensive	self-renewal	capacity	when	cultured	in	the	presence	of	IL-3	[106].	
	
In	 1992,	 Herberlein	 and	 colleagues	 performed	 gene	 expression	 analysis	 of	 a	 number	 of	
different	embryonic	stem	cell	(ESC)	and	HPC	lines,	including	the	FDCP-mix	cell	line	[107].	Using	
reverse	 transcriptase	 polymerase	 chain	 reaction	 (RT-PCR)	 and	 northern	 blot	 analysis,	 the	
authors	showed	that	the	genes	encoding	the	erythropoietin	(Epo)	receptor	(EpoR)	and	the	
erythroid-associated	 TF,	 GATA-1,	 are	 expressed	 in	 erythroid	 committed	 progenitors,	
multipotent	HPCs	and	ESCs.	The	authors	then	performed	DNase	hypersensitivity	analysis	of	
FDCP-mix	 and	 commitment	 progenitor	 cells,	 demonstrating	 that	 the	 accessibility	 of	 the	
chromatin	within	the	EPOR	locus	changes	as	multipotent	cells	commit	to	different	lineages.	
The	chromatin	within	 the	EPOR	 locus	 is	 in	an	open	conformation	 in	multipotent	 cells	 and	
	 23	
either	 becomes	 more	 accessible	 as	 these	 cells	 differentiate	 towards	 erythroid	 fates,	 or	
becomes	less	accessible	as	they	differentiate	towards	non-erythroid	fates.	In	the	same	year,	
Jimenez	et	al.	demonstrated	that	the	β-globin	(HBB)	locus	is	DNase	I	hypersensitive	in	FDCP-
mix	 cells,	 but	 not	 in	 granulocytes	 and	 monocytes	 derived	 from	 granulocyte-macrophage	
colony	 stimulating	 factor	 (GM-CSF)/granulocyte	 colony	 stimulating	 factor	 (G-CSF)	 treated	









hypersensitivity	 within	 the	 CD3D	 and	 IGH	 regions	 [109,	 110].	 The	 expression	 of	 other	
lymphoid-associated	genes,	such	as	GZMB,	has	also	been	confirmed	 in	FDCP-mix	cells	and	
human	CD34+	HPCs	[111,	112].	Finally,	both	Ford	et	al.	[113]	and	Zhu	et	al.	[114]	have	shown	
that	 FDCP-mix	 cells	 express	 low	 levels	 of	 the	 gene	encoding	 the	myeloperoxidase	protein	
(MPO),	which	is	associated	with	the	GM	lineage.	
	
The	 studies	 highlighted	 above	 provided	 early	 evidence	 to	 support	 the	 viewpoint	 that	
multilineage	 gene	 expression	 in	 haematopoietic	 cells	 precedes	 lineage	 commitment.	
However,	 these	 studies	 examined	 gene	 expression	 by	 performing	 analysis	 on	 whole	
populations	of	 cells,	 and	do	not	 exclude	 the	possibility	 that	 a	 number	of	 transcriptionally	
distinct	 subpopulations	 exist	 within	 multipotent	 haematopoietic	 cell	 populations.	 To	
	 24	
investigate	 this	 premise,	 the	 Enver	 group	 has	 performed	 multiplex	 RT-PCR	 analysis	 of	






cells	 co-expressed	 these	 genes,	 displaying	 an	 erythroid-macrophage	 expression	 profile.	
Similarly,	 30%	 of	 cells	 co-expressed	HBB	 and	GCSFR,	 and	 were	 considered	 to	 express	 an	
erythroid-granulocyte	 profile.	 Using	 a	 second	 multiplex	 RT-PCR	 assay,	 the	 group	 then	
investigated	the	co-expression	of	HPRT,	and	the	haematopoietic	growth	factor	(HGF)	receptor	
genes,	KIT,	EPOR,	GCSFR,	IL3R,	GMCSFR,	and	MCSFR.	The	findings	demonstrated	that	FDCP-
mix	cells	are	highly	heterogeneous	 in	 regards	 to	 the	expression	of	HGF	receptors,	and	co-
expression	 of	 these	 genes	 was	 noted	 in	 a	 number	 of	 cells.	 For	 example,	 36%	 of	 the	 87	
individual	cells	assayed	were	positive	for	Csf3r,	Kit	and	Csf2r	mRNA,	while	6%	of	single	cells	
co-expressed	 Csf2r	 and	 Epor	 transcripts.	 The	 expression	 of	 multiple	 lineage-associated	
transcripts	was	then	confirmed	in	purified	mouse	Lin−	CD34+	BM	cells,	demonstrating	that	the	
observed	multilineage	expression	was	not	an	artifact	of	the	FDCP-mix	cell	line.	As	such,	Enver	
and	 colleagues	 were	 the	 first	 to	 provide	 evidence	 for	 the	 expression	 of	 several	 distinct	




expression	 in	HSPCs	 [116].	Using	 single	cell	RT-PCR,	 the	authors	 first	demonstrated	 that	a	











T-lymphocyte	 lineages.	 Finally,	 the	 authors	 demonstrated	 that	 HPCs	 express	 lineage-






patterns	 in	 single	 cells	 resulted	 in	 translation	of	 functional	proteins,	 Enver	and	colleagues	
have	proposed	that	the	increase	in	expression	and	accessibility	of	particular	gene	loci	during	
differentiation	 demonstrates	 a	 transition	 between	 transcriptional	 priming	 and	 protein	
expression	 [115].	 In	 this	 transcriptionally	 primed	 state,	 multilineage	 gene	 expression	 is	
governed	by	stochastic	fluctuations	in	cell-intrinsic	factors,	such	as	lineage-determining	TFs.	
Stochastic	fluctuations	in	cell-intrinsic	factors	have	been	studied	in	many	organisms	and	are	

















to	 investigate	 whether	 fluctuations	 in	 Sca1	 expression	 marked	 distinct	 functional	
subpopulations	[118].	When	cultured	in	the	presence	of	Epo	immediately	after	isolation,	the	
















by	 the	 transition	 of	 cells	 through	 metastable	 states	 that	 display	 differing	 affinities	 for	
particular	cell	fates.	As	highlighted	by	Chang	et	al.,	these	transitions	appear	to	occur	due	to	
fluctuations	 in	 cell-intrinsic	 factors,	 such	 as	 lineage-determining	 TFs,	 which	 generate	
transcriptome	wide	noise	and	mediate	lineage	specification	[118].		Studies	of	prokaryotic	and	
eukaryotic	cells	have	shown	that	stochastic	fluctuations	in	gene	expression	are	affected	by	
many	 factors,	 including	 cell	 size	 and	 location	 of	 gene	 loci	 [119-122].	 However,	 studies	
investigating	regulation	of	gene	expression	during	haematopoietic	lineage	specification	have	
largely	 focused	on	 interactions	between	 lineage-associated	TFs.	 In	particular,	 the	mutually	
antagonistic	interactions	between	GATA-1	and	PU.1	have	been	extensively	characterised.		
	























Given	 the	 interactions	 between	 PU.1	 and	 GATA-1,	 the	 two	 TFs	 are	 thought	 to	 form	 a	
competitive	transcriptional	network,	or	developmental	switch,	that	primarily	regulates	the	
choice	 between	 the	GM-lymphoid	 and	MegE	 lineages.	 Once	 this	 developmental	 switch	 is	
triggered,	the	selected	lineage-associated	transcriptional	program	is	thought	to	be	reinforced	






lineage	 commitment.	 For	 example,	 the	 ratio	 of	 MafB	 to	 PU.1	 expression	 mediates	 the	
	 29	
differentiation	of	myeloid	progenitor	cells	towards	either	a	macrophage	or	DC	fate	 in	vitro	





[137].	 Iwasaki	et	 al.	 transduced	mouse	 CLPs	with	 a	 gene	 construct	 that	 enforced	 C/EBPα	
expression	 and	 reported	 that	 these	 cells	 almost	 exclusively	 formed	 GM	 cells	 in	
methylcellulose	colony	forming	assays	[137].	When	CLPs	were	transduced	to	express	C/EBPα,	
and	then	GATA-2	24	hours	later,	they	only	gave	rise	to	eosinophil	colonies.	Strikingly,	if	CLPs	




in	 haematopoietic	 cells.	 The	 existence	 of	 such	 TF	 developmental	 switches	 has	 increased	
support	for	a	stochastic	model	of	haematopoiesis.		
	
Most	of	 the	 studies	 investigating	 the	existence	of	 TF-driven	developmental	 switches	have	




yellow	 fluorescent	 protein),	 and	 examined	 the	 HSC,	 CMP	 and	 GMP	 compartments	 to	
determine	 if	 GATA-1	 and	 PU.1	 are	 co-expressed	 in	 a	 single	 cell	 at	 any	 time	 during	
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haematopoiesis.	Within	 the	CMP	population	 there	were	 two	discrete	 subpopulations	 that	
could	be	identified	based	on	GATA-1-mCherry	and	PU.1-eYFP	expression;	the	first	exclusively	






HSC	 compartment,	 the	 authors	 only	 detected	 low	 levels	 of	 PU.1-eYFP	 expression.	 In	
contradiction	 with	 a	 stochastic	 model	 of	 haematopoiesis,	 these	 findings	 indicate	 that	 no	










committed	 to	a	GATA-1+	PU.1−	MegE	 fate.	Further	analysis	of	 these	cells	 showed	that	 the	
decrease	in	PU.1-eYFP	was	independent	of	GATA-1-mCherry	expression,	and	in	some	cases	







[138].	 While	 these	 findings	 do	 not	 entirely	 rule	 out	 the	 possibility	 of	 PU.1	 and	 GATA-1	
competitive	 interplay	 occurring,	 they	 strongly	 argue	 against	 a	 stochastic	 model	 of	
commitment	whereby	differentiation	is	initiated	by	a	PU.1/GATA-1	network.	As	this	study	is	
the	first	to	investigate	the	role	of	these	TFs	in	differentiation	at	the	single	cell	level,	further	
work	 will	 be	 required	 to	 confirm	 the	 findings,	 and	 determine	 how	 PU.1	 and	 GATA-1	
expression	are	regulated	in	the	absence	of	developmental	switches.	On	a	technical	note,	it	is	
possible	that	PU.1	and	GATA-1	are	co-expressed	at	levels	below	the	limits	of	detection	for	the	



















HGFs	 shape	haematopoiesis	by	 regulating	 the	 survival,	 proliferation	and	differentiation	of	



























fibroblasts	 in	the	cortex	of	the	kidneys,	 though	perisinusoidal	cells	and	hepatocytes	 in	the	
liver	have	also	been	shown	to	secrete	Epo	[149].	Early	in	vitro	studies	showed	that	Epo	was	






in	 vitro.	 In	 1965,	 Pluznik	 and	 Sachs	 reported	 that	 cell	 suspensions	 prepared	 from	mouse	
spleens	were	only	 capable	of	 forming	granulocyte	colonies	 in	 soft	agar	medium	when	co-
cultured	with	 a	 feeder	 layer	 derived	 from	mouse	 embryo	 cells	 [153].	 The	 following	 year,	













third	 CSF,	multi-CSF,	 also	 known	 as	 interleukin-3	 (IL-3),	was	 purified	 from	 leukaemic	 cell-
conditioned	medium	by	Ihle	and	colleagues	in	1982	[159].	Early	studies	of	IL-3	showed	that	is	
required	for	the	maintenance	of	a	number	of	murine	BM-derived	cell	lines	[160],	and	that	it	
promotes	 BM-derived	 CFU	 to	 form	 a	 number	 of	 different	 colony	 types	 in	 vitro,	 including	
macrophage,	granulocytic	and	megakaryocytic	colonies	[161,	162].	The	final	CSF,	G-CSF,	was	
identified	by	Metcalf	and	coworkers	in	1983.	The	group	purified	G-CSF	from	medium	that	was	

















be	discussed,	 interleukin-1	 (IL-1)	and	 interleukin-7	 (IL-7).	 IL-1	was	 the	 first	member	of	 the	
interleukin	 family	 to	 be	 described,	 and	 was	 purified	 from	 human	 monocyte-conditioned	
medium	in	1980	[172].	IL-1	exists	in	two	forms,	IL-1α	and	IL-1β	[173],	and	is	extremely	diverse	
























was	 cloned	 later	 that	 year	 [139],	 and	 its	 receptor	 was	 identified	 as	 c-Kit	 [193],	 which	 is	
primarily	expressed	by	early	HSPCs	[194].	
	









In	 1989,	 Wendling	 and	 co-workers	 reported	 that	 murine	 BM	 HSPCs	 infected	 with	





by	 megakaryocytes	 [202].	 This	 led	 to	 the	 eventual	 purification	 and	 cloning	 of	 its	 ligand,	
thrombopoietin	(Tpo),	in	1994	[203-205].	While	Tpo	was	quickly	identified	as	an	important	
regulator	of	thrombopoiesis/megakaryocytopoiesis	[206],	it	regulates	HSC	quiescence	[207],	












evidence	 that	 they	 were	 capable	 of	 recruiting	 cells	 into	 active	 cell	 cycling.	 This	 was	 first	
demonstrated	in	the	1980s	using	conditioned	medium	containing	CSFs.	Using	lung-,	spleen-	
and	 leukaemic	 cell-conditioned	 medium	 as	 a	 source	 of	 CSFs,	 Pluznik	 and	 co-workers	
investigated	 the	 effects	 of	 CSFs	 on	 the	 cell	 cycle	 kinetics	 of	 a	 GM-CSF-dependent	 mast	












of	 maintaining	 proliferation.	 Although	 this	 demonstrates	 that	 both	 HGFs	 are	 capable	 of	
stimulating	cell	proliferation,	the	authors	concluded	that	GM-CSFR	is	likely	to	be	absent	from	
quiescent	 HSPCs	 and	 that	 its	 expression	 is	 stimulated	 by	 IL-3	 signalling.	 Shortly	 after	 this	
study,	Spivak	and	co-workers	used	an	erythroleukaemic	cell	line,	HCD-17,	to	demonstrate	the	









suppressing	 apoptosis.	 This	 was	 first	 demonstrated	 by	Williams	 et	 al.	 in	 1990	 [220].	 The	
authors	 investigated	 the	 effects	 of	withdrawing	CSFs	 from	a	 number	 of	 factor-dependent	
FDCP-1	and	FDCP-mix	cell	lines.	Withdrawal	of	IL-3,	GM-CSF	and	G-CSF	from	factor-dependent	
cells	 resulted	 in	 DNA	 fragmentation.	 As	 apoptosis	 is	 dependent	 on	 protein	 synthesis,	 the	
authors	treated	factor-deprived	cells	with	cycloheximide,	a	protein	synthesis	 inhibitor,	and	
noted	that	it	significantly	reduced	the	rate	of	cell	death.	In	the	same	year,	two	independent	








responses	 were	 distinct,	 or	 the	 result	 of	 a	 single	 signalling	 pathway.	 This	 required	
characterisation	of	HGF	receptors,	and	studies	of	G-CSFR	[225],	M-CSFR	[226]	and	IL-3R	[227]	
eventually	revealed	that	these	responses	were	independent	of	each	other.	In	the	case	of	G-
CSFR,	Ward	and	 colleagues	have	 reported	 that	 the	proliferative	and	 survival	 responses	of	
human	G-CSF	(hG-CSF)	signalling	are	mediated	by	different	regions	of	the	G-CSFR	cytoplasmic	
domain	 and	 activate	 two	 distinct	 signalling	 pathways	 [225].	 G-CSFR	 contains	 4	 tyrosine	
residues	within	its	cytoplasmic	domain	that	are	phosphorylated	upon	binding	of	G-CSF.	The	
authors	 transduced	a	myeloid	progenitor	cell	 line,	32D,	with	wild-type	 (WT)	G-CSFR	and	a	
series	of	G-CSFR	mutants	lacking	specific	cytoplasmic	tyrosine	residues.	Cells	transduced	with	
G-CSFR	mutants	lacking	all	four	tyrosine	residues	were	capable	of	surviving	in	the	presence	
of	G-CSFR	 for	 10	days	but	did	not	divide.	 This	 response	was	primarily	mediated	by	 signal	






proliferation	 and	 survival	 of	 haematopoietic	 cells.	 However,	 the	 role	 of	HGFs	 in	HSC	 self-











such	 as	 Epo,	M-CSF,	 G-CSF	 and	 IL-7,	 are	 associated	with	 the	 survival	 and	 proliferation	 of	
particular	lineages.	For	example,	Metcalf	and	Johnson	assessed	the	ability	of	Epo	to	stimulate	
mouse	fetal	 liver	cells	to	form	colonies	in	soft	agar.	When	these	cells	were	cultured	in	the	
presence	 of	 spleen	 conditioned	medium,	 they	 generated	multilineage	 colonies.	 However,	
when	cultured	with	Epo	alone,	they	did	not	form	any	colonies	[228].	Epo	was	only	able	to	
stimulate	these	cells	 to	generate	erythroid	colonies	after	 they	had	been	pre-cultured	with	
spleen	 conditioned	 medium.	 In	 the	 same	 year,	 Udupa	 et	 al.	 examined	 its	 effects	 on	
stimulating	 CFU-S,	 CFU-E	 and	 BFU-E	 proliferation	 in	 mice	 following	 administration	 of	
chemotherapeutic	agents	[229].	After	treatment	with	alkylating	agents,	there	was	a	dramatic	
decrease	 in	 the	number	of	BM	CFU-S,	CFU-E	and	CFU-B,	and	 the	authors	monitored	 their	







Early	 studies	 of	 G-CSF	 suggest	 that	 it	 primarily	 acts	 on	 committed	 progenitors.	 In	 1983,	
Metcalf	 and	 Nicola	 performed	 colony	 forming	 assays	 with	 mouse	 BM	 and	 fetal	 liver	 to	
examine	if	G-CSF	could	promote	colony	formation	in	vitro	[164].	When	BM	and	fetal	liver	cells	






methylcellulose	 medium	 supplemented	 with	 G-CSF,	 only	 7	 granulocytic	 colonies	 were	
observed.	 However,	 when	 IL-3	 was	 added,	 20	 granulocytic	 colonies,	 1	 GM	 colony	 and	 2	
eosinophil	colonies	were	generated.	When	the	BM	cells	were	cultured	in	serum-containing	






lineage-specific	 based	 on	 its	 ability	 to	 promote	 the	 formation	 of	 GM	 colonies,	 but	 some	
studies	 showed	 that	 it	was	 also	 capable	 of	 acting	 on	multipotent	 and	 erythroid	 cells.	 For	
instance,	when	 fetal	 liver	 cells	 are	 cultured	 in	GM-CSF	 for	2	days	and	 then	 transferred	 to	
mouse	 spleen	 cell-conditioned	 medium,	 they	 are	 capable	 of	 forming	 multilineage	 and	
erythroid	 colonies	 [231].	 Similarly,	 the	 addition	 of	 GM-CSF	 to	 serum-free	methylcellulose	
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cultures	 containing	 human	 Lin−	 BM	 cells	 allows	 the	 formation	 of	 erythroid,	 GM	 and	
multipotent	colonies	[232].	
	
The	 categorisation	 of	 HGFs	 based	 on	 their	 lineage-specific	 and	 non-specific	 activities	 led	





specific	HGFs	allows	 for	 the	 selective	expansion	of	 cell	populations.	 For	example,	 in	 cases	
where	 lineage-specific	 HGFs	 promote	 the	 development	 of	 particular	 lineages	 from	
























did	 not	 proliferate	 in	 cultures	 lacking	 HGFs.	 However,	 cytospin	 preparations	 of	 BCL2-
transduced	 FDCP-Mix	 cells	 revealed	 that	 they	matured	 into	 granulocytes,	monocytes	 and	
erythroid	cells	over	an	8-day	period.	Northern	blotting	analysis	of	the	BCL2-transduced	FDCP-
Mix	cells	showed	that	they	did	not	express	the	genes	encoding	GM-CSF	(CSF2),	G-CSF	(CSF3)	
and	 IL-3	 (IL3),	 and	 conditioned	 medium	 from	 these	 cells	 was	 not	 sufficient	 to	 promote	
differentiation	of	untransduced	FDCP-Mix	cells.	This	ruled	out	the	possibility	of	differentiation	











differences	were	observed	during	 initial	 characterisation	of	CSF2−/−,	 as	 they	 showed	more	
variability	in	the	weight	of	their	spleens	and	granulocyte	counts	when	compared	to	control	
animals.	However,	the	lung	physiology	of	CSF2−/−	mice	is	significantly	different	from	WT	mice.	
CSF2−/−	 have	 increased	 numbers	 of	 infiltrating	 lymphocytes	 and	 large	 intra-alveolar	











lineage	 committed	 progenitors.	 HSC,	 haematopoietic	 stem	 cell;	 IL-3,	 interleukin-3;	 IL-7,	
interleukin-7;	 SCF,	 stem	 cell	 factor;	M-CSF,	 macrophage-colony	 stimulating	 factor;	 G-CSF,	



























Mice	 lacking	 M-CSFR	 have	 decreased	 numbers	 of	 macrophages	 and	 osteoclasts	 when	
compared	to	littermate	controls	[243,	244].	However,	CSF1R−/−	mice	have	similar	numbers	of	
BM	 macrophage	 progenitors	 to	 WT	 mice	 and	 heterozygous	 CSF1R+/−	 controls,	 when	
compared	using	colony	forming	assays	[245].	Lagasse	and	Weissman	have	demonstrated	that	
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ectopic	 expression	 of	 human	 Bcl2	 in	 CSF1R−/−	 myeloid	 cells	 partially	 restores	
monocyte/macrophage	 counts	 in	 vivo	 [246].	 Using	 a	 BCL-MRP8	 transgene,	 the	 authors	





Although	 these	 knock-out	 studies	 support	 a	 permissive	 role	 of	 HGFs,	 they	 should	 be	
interpreted	 with	 caution.	 Firstly,	 they	 do	 not	 exclude	 the	 possibility	 of	
compensatory/redundant	mechanisms	 between	 the	 actions	 of	 HGFs.	 For	 instance,	 G-CSF,	
GM-CSF	and	M-CSF	all	stimulate	the	growth	of	GM	cells.	Secondly,	 in	the	case	of	receptor	




Some	 studies	 that	 have	 investigated	 the	 ectopic	 expression	 of	 HGF	 receptors	 in	 lineage-
restricted	cells	suggest	that	these	do	not	influence	lineage	specification.	In	1994,	Pharr	and	
colleagues	 transduced	 blast	 cell	 colonies	 with	 a	 constitutively	 active	 viral	 form	 of	 EpoR,	
EPOR(R129C),	or	human	M-CSFR	(hM-CSFR)	and	examined	their	ability	 to	 form	colonies	 in	
vitro	 [247].	 In	 the	presence	of	 SCF,	 IL-3	 and	Epo,	 EPOR(R129C)-transduced	 cells	 produced	
comparable	numbers	of	erythroid	and	GM	colonies	when	compared	to	control	cells,	though	
the	colonies	were	larger.	Similarly,	when	cultured	with	IL-3	and	M-CSF,	hM-CSFR-transduced	
cells	 and	 control	 cells	 generated	 comparable	 numbers	 of	 GM	 colonies,	 with	 similar	
macrophage	 compositions.	 Although,	 M-CSFR	 transduced-cells	 displayed	 increased	
secondary	 plating	 efficiency	 when	 compared	 to	 control	 cultures.	 As	 such,	 the	 authors	
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mouse	 fetal	 liver	 cells	 and	 BM	 cells	 from	 5-fluorouracil	 treated	 mice	 with	 M-CSFR	 and	
assessed	their	colony	forming	potential.	M-CSF	was	capable	of	maintaining	EPs,	and	increased	
the	number	of	megakaryocyte	and	GM	colonies	formed	when	compared	to	cells	transduced	
with	 an	 empty	 vector.	 These	 findings	 suggest	 that	 M-CSF	 signalling	 provides	 permissive	
proliferative	cues,	and	does	not	instruct	lineage	specification.	
	
Some	 studies	 using	 chimeric	 fusion	 HGF	 receptors	 have	 also	 provided	 evidence	 of	 a	
permissive	model	of	HGF	activity.	Stoffel	et	al.	generated	a	chimeric	Mpl	receptor	by	replacing	
its	cytoplasmic	domain	with	the	cytoplasmic	domain	of	G-CSFR	[249].	This	receptor,	which	
binds	Tpo	and	 stimulates	G-CSFR-mediated	 intracellular	 signalling,	was	 introduced	 into	an	
MPL−/−	mouse	strain	to	prevent	Mpl	signalling	in	vivo.	Characterisation	of	these	mice	revealed	
similar	platelet	and	granulocyte	counts,	and	comparable	numbers	of	BM	megakaryocyte	and	
GM	progenitors	 to	WT	 controls.	 Using	 a	 similar	 approach,	 Semerad	et	 al.	 have	 created	 a	
transgenic	mouse	model	that	expresses	a	chimeric	receptor	that	binds	G-CSF	and	transmits	
EpoR	signalling	[250].	These	mice	have	normal	granulopoiesis	and	erythropoiesis.	However,	




Finally,	Mayani	 and	 co-workers	 have	 provided	 evidence	 for	 a	 permissive	 role	 of	 HGFs	 in	
human	haematopoiesis	by	analysing	the	fate	of	paired	multipotent	daughter	cells	cultured	in	
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the	 presence	 of	 different	 HGFs.	 [251].	 Individual	 CD34+	 CD45RAlo	 CD71lo	 haematopoietic	









58%	 of	 paired	 daughter	 cells	 gave	 rise	 to	 similar	 colonies	 (29%	 GM,	 14%	 erythroid,	 15%	
mixed).	In	31%	of	EGFC/EGFC	cases,	the	daughter	cells	generated	colonies	of	different	types.	
This	included	cases	where	cells	formed	small	cell	clusters	that	could	not	be	identified	due	to	
limited	 cell	 numbers.	 In	 the	 remaining	 cases,	 both	 cells	 generated	 small	 unidentifiable	
clusters.	In	cases	where	daughter	cells	were	placed	in	separate	myeloid	growth	factor	cultures	
(MGFC/MGFC),	67%	of	colonies	formed	the	same	colony	type	(47%	GM,	3%	mixed,	17%	small	
unidentifiable	 cell	 clusters).	 In	 3%	of	MGFC/MGFC	 cases,	 one	daughter	 cell	 gave	 rise	 to	 a	
mixed	colony	while	the	other	gave	rise	to	a	GM	colony.	In	30%	of	MGFC/MGFC	cases,	one	
daughter	cell	gave	rise	to	a	GM	colony	while	the	other	formed	a	small	unidentified	cluster.	











unidentified	 clusters,	 either	 this	 occurred	 as	 a	 result	 of	 manipulation	 or	 these	 colonies	
contained	cells	 that	could	not	 thrive	 in	particular	HGF	mixtures	 [251].	For	example,	 in	 the	











control	 cultures.	 Examination	 of	 MEP	 proliferation	 revealed	 that	 there	 was	 a	 significant	





haematopoiesis	 whereby	 cell	 fate	 is	 governed	 by	 cell-intrinsic	 stochastic	 processes,	 and	
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proliferation	 and	 survival	 are	 mediated	 by	 cell-extrinsic	 factors.	 However,	 other	 studies	
carried	 out	 at	 the	 same	 time	 disagree	 with	 such	 a	 model,	 and	 provide	 evidence	 for	 an	
instructive	role	of	HGFs.	This	model	will	be	discussed	below.	
	








erythroid,	 20%	 were	 granulocytic,	 15%	 were	 megakaryocytic	 and	 2%	 were	 eosinophilic,	
suggesting	that	the	spleen	microenvironment	regulated	the	lineage	commitment	of	CFU-S.	In	
a	subsequent	study,	Wolf	and	Trentin	demonstrated	that	BM	stroma	selectively	promoted	





proposed	 the	 existence	 of	 distinct	 stromal	 haematopoietic	 inductive	 microenvironments	
(HIMs)	that	regulate	the	fate	of	HSPCs,	although	it	was	unclear	how	at	the	time	[255].	
	









(50	units).	Of	 the	 41	 cases	where	 at	 least	 one	 cell	 formed	a	 colony	 (>50	 cells),	 15	paired	
daughter	 cells	 displayed	 differing	 lineage	 potentials.	 The	 progeny	 cultured	 in	 medium	
containing	2,500	units	GM-CSF	were	more	 likely	 to	 form	colonies	containing	granulocytes,	
while	 progeny	 cultured	 in	 the	 presence	 of	 50	 units	 GM-CSF	 formed	 more	 macrophage-
containing	colonies.	In	the	remaining	cases,	paired	daughter	cells	formed	colonies	of	similar	
lineage	 composition	 and	 size.	 In	 a	 second	 experiment,	 both	 paired	 daughter	 cells	 were	
transferred	into	separate	cultures	containing	2,500	units	of	GM-CSF.	At	least	one	colony	(>50	
cells)	 was	 detected	 in	 48	 cases,	 and	 in	 45	 of	 these	 cases	 the	 daughter	 cells	 generated	
colonies/clusters	 of	 similar	 lineage	 composition	 and	 size.	 Statistical	 analysis	 of	 these	
experiments	showed	that	dissimilar	colony	 formation	 from	paired	daughter	cell	 formation	












the	 other	was	 cultured	 in	 GM-CSF.	When	 cells	 were	 pre-cultured	with	M-CSF	 before	 cell	
division,	88%	of	the	progeny	separated	into	M-CSF	formed	colonies	containing	macrophages,	
while	56%	of	progeny	separated	into	medium	containing	GM-CSF	formed	colonies	containing	
granulocytes.	 In	 a	 parallel	 experiment,	 cells	 were	 pre-cultured	 with	 GM-CSF	 before	 cell	
division.	Eighty-six	percent	of	daughter	cells	transferred	to	media	containing	GM-CSF	formed	
colonies	containing	granulocytes,	while	76%	of	daughter	cells	transferred	to	M-CSF	containing	
cultures	 formed	colonies	 containing	macrophages.	The	authors	noted	 that	 the	progeny	of	
cells	cultured	in	GM-CSF	prior	to	cell	division	were	statistically	more	likely	to	form	granulocyte	

















that	 argue	against	 the	permissive	action	of	HGFs,	 and	provide	evidence	against	 individual	
aspects	of	a	stochastic	model	of	haematopoiesis.	Firstly,	a	role	for	HGFs	in	the	maturation	of	
HSPCs	 is	 supported	 by	 studies	 that	 have	 investigated	 the	 effects	 of	 HGF	 stimulation	 on	
leukaemic	 cell	 lines.	 A	 number	 of	 independent	 studies	 have	 shown	 that	 both	human	 and	
mouse	 G-CSF	 suppresses	 proliferation	 and	 stimulates	 the	 terminal	 differentiation	 of	 the	











of	 the	 four	 tyrosine	 residues	 in	 the	 cytoplasmic	 region	 of	 G-CSF	 have	 demonstrated	 that	
tyrosine	 residues	 at	 positions	 704,	 729	 and	 744	 are	 involved	 in	mediating	 differentiation	
signals	 [225,	 265].	 Furthermore,	 mutations	 in	 human	 CSF3R	 that	 result	 in	 proteins	 with	










suggest	 that	 G-CSF	 [268]	 and	 Epo	 [269]	 stimulate	 HPCs	 to	 differentiate	 towards	 the	
granulocyte	and	erythroid	lineages,	respectively.	These	HGFs	are	shown	as	examples,	though	
there	 are	 a	 number	of	 other	HGFs	 that	 have	been	 reported	 to	 instruct	 lineage	 fate.	HSC,	







CSFR	has	 4	 tyrosine	 residues	 in	 the	 cytoplasmic	 region	 that	 are	 phosphorylated	 following	
ligand	binding.	Rohrschneider	et	al.	transduced	a	series	of	M-CSFR	mutants	into	FDCP-1	cells	
and	 demonstrated	 that	 the	 tyrosine	 residue	 at	 position	 807	 is	 essential	 to	 mediate	
differentiation	of	these	cells	in	the	presence	of	M-CSF	[270].	The	other	three	tyrosine	residues	
at	positions	697,	706,	and	721	promote	maturation,	but	are	are	not	required.	Regions	within	
both	 the	 α	 and	 β	 subunits	 of	 human	 GM-CSFR	 (hGM-CSFR)	 have	 also	 been	 shown	 to	 be	
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important	 in	 inducing	 differentiation.	 Transduction	 of	 the	myelomonocytic	 leukaemia	 cell	
lines	 M1	 and	 WEHI-3B	 with	 hGM-CSFR	 containing	 a	 WT	 β	 subunit	 promotes	 their	
differentiation	when	cultured	with	GM-CSF	[271].	However,	when	these	cells	are	transduced	
with	 hGM-CSFR	 containing	 a	 truncated	 β	 subunit	 lacking	 the	 amino	 acid	 residues	 from	
position	541	to	897,	GM-CSF	does	not	stimulate	differentiation.	Similarly,	mutant	GM-CSFR	α	
subunits	 that	 lack	 a	 proline	 residue	 at	 either	 position	 385	 or	 360	 are	 unable	 to	 transmit	
differentiation	signals	when	transduced	into	FCDP-1	cells	[272].	
	
Targeted	 disruption	 of	 the	Mpl	 cytoplasmic	 domain	 also	 suggests	 that	 Tpo	 can	 stimulate	
maturation.	 In	1996,	Alexander	et	al.	 transduced	two	myelomonocytic	 leukaemia	cell	 lines	




northern	 blotting	 analysis.	 In	 contrast,	 cells	 transduced	 with	 the	 mutant	 Mpl	 receptors	
displayed	 an	 impaired	 ability	 to	 form	 differentiated	 colonies	 when	 stimulated	 with	 Tpo.	
Targeted	disruption	of	 specific	 tyrosine	 residues	 in	 the	 cytoplasmic	domain	of	 the	Mpl	C-








In	 contrast	 to	 the	 above	 study,	 ectopic	 expression	 of	 other	 HGF	 receptors	 by	 lineage-












Carroll	 and	 colleagues	 have	 demonstrated	 that	 transduction	 of	 mouse	 EpoR	 into	 pro-B-
















3	and	SCF	 for	10	days.	 Self-renewal	of	 these	cells	was	assessed	by	 the	number	of	 LTC-ICs	













correct.	With	 the	 exception	 of	 studies	 examining	 the	 fate	 of	 paired	 daughter	 cells,	 most	
investigations	 have	 been	 limited	 by	 their	 ability	 to	 thoroughly	 examine	 and	 monitor	
differentiation	at	the	single	cell	 level.	Furthermore,	a	number	of	reports	have	manipulated	
haematopoietic	cells	to	ectopically	express	HGF	receptors.	As	a	result,	theses	studies	do	not	
provide	 an	 understanding	 of	 how	 HGFs	 influence	 the	 lineage	 commitment	 of	 individual	
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In	 2009,	 Rieger	 et	 al.	 provided	 the	 first	 real-time	 analysis	 of	 HPC	 differentiation	 in	 the	
presence	 of	 cytokines	 at	 the	 single	 cell	 level	 [268].	 The	 authors	 purified	 GMPs	 from	 a	
LYSM:eGFP	transgenic	mouse	model,	in	which	the	enhanced	green	fluorescent	protein	(eGFP)	
is	expressed	under	the	control	of	the	LysozymeM	gene	locus,	and	monitored	them	in	culture	









selective	 expansion	 of	 unilineage	 progenitors,	 the	 authors	 monitored	 the	 death	 and	
maturation	of	 individual	GMPs	 following	G-CSF	or	M-CSF	 treatment	 using	 live	 imaging.	 In	
cultures	containing	M-CSF,	88	±	2	%	of	individual	cells	matured	to	form	eGFP+	macrophage	

















PU.1+	 HSC	 subpopulation.	 Following	 16	 hours	 of	 culture	 in	 the	 presence	 of	 M-CSF,	
transcriptome	 analysis	 revealed	 an	 increase	 in	 the	 expression	 of	GM-associated	 genes	 by	
















revealed	 that	 this	 decrease	 is	 largely	 due	 to	 the	 reduced	 number	 of	 Ly6D+	 CLPs,	 a	
subpopulation	of	CLPs	that	is	restricted	to	the	B-lymphocyte	lineage	[285].	When	Ly6D+	CLPs	
from	 IL7−/−	mice	were	cultured	on	an	OP9	stromal	 layer	 in	 the	presence	of	 IL-7	and	other	
supplementary	 HGFs,	 they	 were	 capable	 of	 generating	 both	 NK	 lymphocytes	 and	 B-
lymphocytes.	 This	 was	 in	 contrast	 to	 Ly6D+	 CLPs	 from	 WT	 mice	 which	 only	 formed	 B-





WT	 mice.	 Previous	 work	 has	 shown	 that	 the	 enforced	 expression	 of	 EBF1	 in	 IL7R−/−	 BM	
progenitors	restores	B-lymphopoiesis	[286],	and	EBF1	has	been	proposed	to	be	a	target	of	IL-
7	signalling	[287].	Thus,	Tsapogas	and	colleagues	investigated	whether	EBF1	deficient	mice	
displayed	a	 similar	phenotype	 to	 IL7−/−	mice	 [284].	 Indeed,	when	single	EBF1−/−	CLPs	were	
seeded	onto	OP9	feeder	layers,	in	the	presence	of	the	relevant	HGFs,	they	were	capable	of	
developing	 into	 NK	 lymphocytes,	 but	 not	 B-lymphocytes.	 Analysis	 of	 EBF1−/−	 mice	
demonstrated	 that	 they	 had	 normal	 levels	 of	 Ly6D−	 and	 Ly6D+	 CLPs,	 indicating	 that	 the	







Tsapogas	 et	 al.	 have	 also	 proposed	 that	 Flt3	 signalling	 influences	 HSPC	 fate	 [288].	 They	
developed	 a	 transgenic	mouse	model	 (FLT3L-Tg)	 which	 expresses	 the	 human	 FLT3L	 gene	






population.	 There	 are	 two	 possible	 explanations	 for	 this;	 i)	 Flt3L	 selectively	 expands	 all	
haematopoietic	 progenitor	 populations	 except	 MEP,	 or;	 ii)	 Flt3L	 drives	 early	 HSPCs	 to	







It	 should	be	noted	 that,	while	 the	 study	by	 Tsapogas	et	al.	 suggests	 Flt3L	 acts	 to	 instruct	
lineage	fate,	the	data	provided	does	not	exclude	the	possibility	of	selective	expansion	of	non-
MegE	 progenitors.	 A	 figure	 for	 the	 absolute	 number	 of	MEPs	was	 not	 provided	 from	 the	










an	 expansion	 of	 committed	 erythroid	 and	 MegE	 progenitors,	 whereas	 megakaryocyte	
progenitor	(MkPs),	preGMP,	GMP	and	LMPP	populations	were	decreased.	When	examining	

























There	 is	 also	 evidence	 to	 suggest	 that	 other	 extrinsic	 factors,	 such	 as	 hormones	 and	
metabolites,	influence	the	lineage	specification	of	HSPCs.	In	2014,	Oburoglu	and	colleagues	
isolated	 CD34+	 CD38−	 hHSCs	 and	 investigated	 the	 effects	 of	 inhibiting	 glutaminolysis	 or	
glycolysis	on	Epo-mediated	erythroid	specification	in	vitro	[289].	First,	the	authors	performed	
small-hairpin	(sh)RNA-mediated	knock-down	of	the	glutamine	transporter	gene,	ASCT2,	and	
examined	 the	 differentiation	 of	 hHSCs	 towards	 the	 erythroid	 lineage	 by	 monitoring	 the	
expression	of	the	erythroid-associated	cell	surface	marker,	glycophorin	A.	Following	6	days	of	
culture,	only	10%	of	 shASCT2-transduced	hHSCs	had	acquired	expression	of	glycophorin	A	
when	 compared	 to	 40-80%	 of	 control	 cells.	 In	 contrast,	 approximately	 50%	 of	 shASCT2-
transduced	hHSCs	 differentiated	 into	 CD11b+	myeloid	 cells.	 Similar	 results	were	 observed	
when	hHSCs	were	treated	with	a	glutiminase	inhibitor.	When	the	authors	inhibited	glycolysis	
in	 hHSCs	 using	 a	 phosphoglucoisomerase	 inhibitor,	 an	 increased	 number	 of	 these	 cells	
differentiated	 into	 erythroid	 cells	 in	 the	 presence	 of	 Epo.	 Finally,	 these	 findings	were	 re-





towards	 a	 lymphoid	 fate	 [290].	 LMPPs	 that	 were	 pre-treated	 with	 insulin	 for	 18	 hours	
produced	significantly	more	lymphoid	cells,	at	the	expense	of	myeloid	cells	in	colony	forming	
and	in	vivo	transplantation	assays	when	compared	to	untreated	cells.	Using	gene	expression	
analysis,	 the	 authors	 demonstrated	 that	 insulin	 stimulated	 the	 expression	 of	 IKZF1,	 a	










to	 refute	 a	 model	 in	 which	 HGFs	 act	 in	 a	 selective	 manner.	 For	 example,	 the	 studies	














cells	are	considered	 to	be	biased	because	 they	disproportionately	 contribute	 to	particular	
lineages	when	compared	to	the	average	output	of	the	population.	In	2002,	Sieburg’s	group	
performed	 long-term	 reconstitution	 assays	 using	 the	 progeny	 derived	 from	 single	mouse	
HSCs	 in	 vitro	 [291].	 These	 experiments	 revealed	 three	 subpopulations	 of	 HSCs	 that	 were	
capable	of	generating	cells	with	distinct	repopulating	characteristics;	balanced	HSCs,	which	







at	 levels	 approximately	 2.2-fold	 lower	 than	 those	 derived	 from	 LyHSCs	 [292].	 When	 the	
progeny	of	MyHSCs	were	cultured	in	vitro,	they	failed	to	respond	to	IL-7	stimulation.	These	
cells	generated	the	same	number	of	lymphoid	cells	in	culture	regardless	of	whether	IL-7	was	
present.	 As	 such	 the	 authors	 concluded	 that	 the	 bias	 of	 these	MyHSCs	 and	 LyHSCs	 was	
dependent	on	varying	patterns	of	HGF	receptor	expression	[292].	Further	analysis	of	aging	
mice	 by	 Cho	et	 al.	 revealed	 that	 the	MyHSC	 pool	 increased	 at	 the	 expense	 of	 the	 LyHSC	
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of	 Hoechst	 33342	 [25].	MyHSCs	 were	 identified	 as	 the	 lower	 side	 population	 (SP),	 while	
LyHSCs	represent	the	upper	SP,	allowing	for	isolation	and	further	characterisation	of	these	





also	 demonstrated	 that	 MyHSCs	 are	 enriched	 for	 in	 the	 CD150hi	 fraction	 of	 the	 LSK	
compartment	of	the	BM	[27,	294].	Shimazu	and	colleagues	have	identified	a	LyHSC	population	







vWF–	 HSCs.	 Using	 single	 cell	 transplantation	 assays,	 the	 authors	 showed	 that	 vWF+	 HSCs	










granulocyte-	 and	DC-biased	HSCs	 in	mice	 [9,	 28].	 This	 technique	allows	 for	 the	 tagging	of	
individual	cells	with	a	unique	genetic	sequence	from	a	 library	of	randomly	generated	DNA	
sequences,	 and	 has	 been	 used	 to	 monitor	 the	 differentiation	 of	 HSPCs	 during	 BM	
transplantation	 assays.	 Donor	 cells	 are	 first	 transduced	 with	 lentiviruses	 containing	
sequences	 from	 a	 DNA	 library,	 resulting	 in	 the	 labelling	 of	 individual	 cells	 with	 a	 unique	
barcode.	 The	 donor	 cells	 are	 then	 transplanted	 into	 recipients,	 and	 high-throughput	
sequencing	of	haematopoietic	cells	is	used	to	determine	the	contribution	of	each	individual	
HSPC	 to	 the	haematopoietic	 system.	The	Weissman	 [28]	and	Schumacher	 [9]	groups	have	




Lineage-restricted	 cells	 with	 long-term	 repopulating	 activity	 have	 also	 been	 identified.	
Yamamoto	et	al.	have	identified	three	long-term	repopulating	myeloid-restricted	progenitor	
(MyRP)	 subpopulations	 within	 the	 HSC	 compartment	 of	 the	 mouse	 BM	 [23].	 The	 group	
















lineage	 restricted	 progenitors	 [23].	 The	 authors	 concluded	 that	 currently	 defined	 HSPC	
populations	are	not	comprised	of	homogeneous	progenitors	with	similar	lineage-potentials.	
Rather,	 they	 contain	 a	 number	 of	 distinct	 subpopulations	 that	 together	 contribute	 to	 the	
lineage	potential	of	the	whole	population.	
	






this	 suggests	 that	 HGFs	 are	 instructive.	 As	 highlighted	 in	 Section	 1.3.2.4,	 analysis	 of	 HGF	
receptor	expression	within	different	compartments	will	help	to	provide	clarity	on	whether	







can	 instruct	HSPC	 fate,	while	other	 studies	 indicate	 that	HGFs	act	permissively.	 The	exact	
mechanisms	 that	 govern	 lineage	 commitment	 in	 HSPCs	 remains	 unclear.	 It	 is	 also	 largely	
unknown	how	heterogeneous	HSPC	populations	are	in	regards	to	their	response	to	HGFs.	For	




such	 subpopulations	of	 cells	 exist	within	 the	early	HSPC	 compartments,	 then	HGFs	would	
selectively	stimulate	these	subpopulations	to	drive	their	differentiation.	This	would	suggest	









and,	 as	 highlighted	 in	 Section	 1.3,	 have	 considered	 these	 two	 properties	 to	 be	mutually	




on	 the	 action	 of	 HGFs	 is	 possibly	 an	 oversimplification	 of	 an	 extremely	 complex	 process,	
especially	 considering	 the	 heterogeneity	 of	 HSPCs.	 To	 further	 explore	 this	 postulate,	 the	
analysis	of	HGF	receptor	expression	at	the	single	cell	level	is	required,	with	particular	focus	











of	 the	 BM.	 Expression	 of	HGF	 receptor	 protein	within	 each	HSPC	 compartment	was	 then	
investigated	and	the	data	was	compared	with	the	findings	from	the	qRT-PCR	studies.	Finally,	
in	vitro	 culture	experiments	were	undertaken	to	examine	 the	 responsiveness	of	particular	













2.2			Analysis	 of	 HemaExplorer	 and	 BloodSpot	
databases	
Raw	values	for	FLT3,	EPOR,	CSF1R	and	CSF3R	expression	by	HSPCs	were	exported	from	the	
HemaExplorer	 and	 BloodSpot	 databases	 [296,	 297].	 When	 searching	 for	 genes	 in	 the	
databases,	the	‘Mouse	normal	haematopoietic	system’	dataset	was	selected.	This	included	
LT-HSC,	ST-HSC,	LMPP,	CLP,	ETP,	pro-B-lymphocytes,	pre-B-lymphocytes,	preGM,	GMP,	MEP,	
MkP,	 preCFU-E,	 CFU-E	 and	 EP	 populations.	 Other	 populations	 were	 also	 included	 in	 the	
dataset	 but	 these	 were	 excluded,	 as	 they	 were	 not	 relevant	 to	 this	 study.	 Data	 was	
downloaded	in	Microsoft	Excel	format	from	the	website.	Where	the	data	included	more	than	
one	set	of	results,	all	results	were	averaged	and	the	mean	was	included	in	the	data	analysis.	










were	obtained	during	experiments.	 To	prepare	 the	hindlimb	 for	processing,	 scissors	were	
used	 to	 cut	 through	 the	 pelvis	 of	 the	 mouse,	 removing	 the	 femur,	 tibia	 and	 fibula.	 This	






bones	were	 cleaned	of	muscle	 and	 fat.	Of	 the	 forelimb,	only	 the	humerus	and	ulna	were	
retained	as	the	radius	and	scapula	did	not	contain	a	significant	amount	of	BM.		
	
Unless	 otherwise	 stated,	 cells	 were	 flushed	 from	 the	 BM	 cavity	 using	 a	 1mL	 syringe	 (BD	











394	 rcf	 for	 4	minutes.	 The	 pellet	 was	 resuspended	 in	 buffer	 or	 cell	 culture	medium	 and	
processed	as	required.	
	




were	 lysed,	 cells	 were	 resuspended	 in	 FACS	 buffer,	 divided	 into	 multiple	 samples	 and	
transferred	to	non-sterile	v-bottomed	96-well	plates	(Greiner	Bio-One,	Gloucestershire,	UK).	
The	 samples	 were	 then	 pelleted	 at	 4˚C,	 394	 rcf	 for	 4	 minutes	 and	 the	 supernatant	 was	
removed	by	rapidly	turning	the	plates	upside	down	over	the	sink.	Unless	CD16/32	expression	
was	 examined	 using	 fluorescently-labelled	 antibodies	 (as	 needed	 for	 myeloid	 progenitor	
analysis),	cells	were	incubated	with	anti-CD16/CD32	for	20	minutes	to	block	CD16	(FcγIII)	and	
CD32	 (FcγII)	 receptors,	 prior	 to	 staining.	After	 blocking,	 samples	were	 then	 stained	 in	 50-
100μL	FACS	buffer	containing	antibody	cocktails	or	a	single	antibody	for	compensation	for	at	
least	1	hour	on	ice.	Following	staining,	samples	were	washed	twice	using	FACS	buffer,	and	
subsequently	 resuspended	 in	 FACS	buffer.	 Cells	were	 finally	 filtered	using	 Partec	 CellTrics	
sterile	 filters	 (Sysmex-Partec,	 Münster,	 Germany)	 and	 transferred	 to	 polypropylene	 FACS	
tubes	 (Thermo	 Fisher	 Scientific).	 Samples	 were	 acquired	 using	 a	 CyAN	 FACS	 Analyser	











and	 transferred	 to	 sterile	 1.5	 mL	 Eppendorfs	 (Eppendorf,	 Stevenage,	 UK)	 before	 being	
pelleted	at	4˚C,	394	rcf	for	4	minutes.	Unless	analysing	CD16/32	expression,	Fc	receptors	were	
blocked	as	per	Section	2.4.		As	most	of	the	cells	from	a	single	mouse	were	processed	when	

























































Once	 sorting	 was	 complete,	 PCR	 plates	 were	 sealed	 with	 adhesive	 PCR	 film	 and	 were	
immediately	frozen	and	stored	at	-80˚C	until	required.	Sorting	was	carried	out	using	either	a	
MoFlo	High	Speed	Sorter	(Beckman	Coulter)	or	a	MoFlo	Astrios	(Beckman	Coulter)	controlled	







2.6			Antibody	 titration	 for	 fluorescent	 activated	 cell	
sorting	and	flow	cytometric	analysis	
	

























































Information	 regarding	 a	 gene	 of	 interest	 was	 obtained	 by	 searching	 Ensembl	 Genome	












































qRT-PCR	 assays	 were	 only	 designed	 to	 be	 specific	 for	 regions	 spanning	 exon	 junctions.	
Additionally,	 as	 the	qRT-PCR	 assays	were	 intended	 to	 detect	 all	 protein	 coding	 transcripts	
within	a	cell,	all	protein	coding	transcripts	for	a	gene	of	interest	were	analysed	to	determine	




BLAST	 mouse	 genomic	 database	 was	 used	 to	 analyse	 the	 mRNA	 sequences	 flanking	 the	







interactive	 program	 hosted	 by	 Biosearch	 Technologies	 (California,	 USA),	 was	 used.	 The	
RealTimeDesign	Software	calculates	the	best	primers	and	hydrolysis	probe	sequences	for	a	
chosen	DNA	 sequence	based	on	melting	 temperature,	 length	 and	 internal	 stability.	 It	 also	





greater	 specificity	 and	 are	 required	 for	 the	 combination	 of	 assays	 in	 duplex/multiplex	
reactions,	so	all	of	the	assays	that	were	designed	for	this	thesis	were	hydrolysis	probe-based.		
	
Using	 the	 RealTimeDesign	 Software,	 sequences	 (usually	 containing	 100	 nucleotides	 either	
side	 of	 a	 candidate	 exon	 junction)	 were	 input	 and	 the	 specific	 location	 of	 an	 exon-exon	
junction	was	marked	using	the	‘^’	key.	This	allowed	the	software	to	tailor	the	hydrolysis	probe	

































to	ensure	accurate	and	sensitive	amplification	of	 transcripts	 in	 single	cells.	 Firstly,	 limiting	
concentrations	of	the	forward	and	reverse	primers	of	each	qRT-PCR	assay	were	determined.	
For	each	assay,	both	primer	sequences	were	tested	in	variable	combinations.	This	included	
final	 experimental	 concentrations	of	 300nM,	200nM,	100nM,	80nM,	60nM	and	40nM.	All	




and	 DNA)	 and	 an	 excess	 concentration	 of	 hydrolysis	 probe	 (250nM)	 remained	 constant,	











stocks	were	dispensed	 into	the	LightCycler	480	384-well	plate	 to	bring	reactions	 to	a	 final	
volume	of	6μL.	An	example	of	the	master	mix	used	for	primer	optimisation	protocols	is	shown	
































this	 reaction	was	 considered	 to	have	non-limiting	amounts	of	both	primers.	 To	 select	 the	
optimal	 limiting	 primer	 concentrations,	 two	 parameters	 in	 each	 reaction	 were	 analysed.	
Firstly,	the	threshold	cycle	(Ct)	for	each	reaction	was	calculated.	Any	reactions	that	had	a	Ct	
value	 that	was	 >0.5	 cycles	 greater	 than	 the	Ct	 value	of	 the	300nM/300nM	 reaction	were	
considered	to	have	compromised	efficiency,	so	they	were	excluded	from	selection.	Secondly,	
the	level	of	fluorescence	at	the	end	of	the	plateau	phase	of	the	reactions	was	calculated,	and	


















































































































































Optimum	 hydrolysis	 probe	 concentrations	 for	 qRT-PCR	 assays	 were	 determined	 using	 a	
similar	 protocol	 as	 described	 in	 Section	 2.8.2.	 The	 hydrolysis	 probes	 were	 analysed	 at	
concentrations	of	250nM,	225nM,	200nM,	175nM,	150nM,	125nM,	100nM,	75nM,	50nM	and	
25nM.	 Reactions	 were	 performed	 with	 3	 technical	 triplicates,	 and	 mean	 values	 for	 each	



































Figure	 2.6.	 Optimisation	 of	 hydrolysis	 probe	 concentrations	 for	 a	 qRT-PCR	 assay.	 The	
reference	 reaction,	 containing	 250nM	 of	 hydrolysis	 probe,	 is	 used	 to	 select	 a	 primer	
concentration	combination	(250nM	reaction).	Firstly,	reactions	that	had	a	Ct	value	that	was	
>0.5	 cycles	 greater	 than	 the	 Ct	 value	 of	 the	 reference	 reaction	 (250nM	 reaction)	 were	























Any	 reactions	 that	 had	 a	 Ct	 value	 that	 was	 >0.5	 cycles	 greater	 than	 the	 Ct	 value	 of	 the	
reference	reaction	were	considered	to	have	lost	efficiency	due	to	low	probe	concentrations,	
so	 they	 were	 excluded	 from	 selection.	 Amongst	 the	 remaining	 reactions,	 the	 lowest	
concentration	of	hydrolysis	probe	was	selected	as	the	optimum	concentration.	If	all	reactions	












plates.	 Reactions	 were	 prepared	 on	 ice,	 for	 a	 final	 reaction	 volume	 of	 6uL.	 No	 template	
controls	(NTCs)	and	reactions	without	reverse	transcriptase	(-RT)	were	prepared	and	loaded	
into	 the	 plate	 as	 controls	 for	 complementary	 DNA	 (cDNA)	 contamination	 and	 gDNA	
amplification,	respectively.	For	the	single-cell	samples,	a	master	mix	was	prepared	containing	






















































Stage	 Length	 Temperature	 Description	 	






2-step	cycling	 	 	 	 	




















according	 to	 the	 manufacturer’s	 instructions.	 Firstly,	 100μL	 of	 the	 CD114	 antibody	 was	

















2.5.	 Unless	 otherwise	 stated,	 cells	 were	 double	 sorted	 into	 Eppendorfs	 containing	 500μL	
Iscove's	Modified	Dulbecco's	Media	 (IMDM,	Thermo	Fisher	Scientific)	 containing	10%	FCS,	
1,000 U/mL	penicillin	and	1,000 μg/mL	streptomycin	(Thermo	Fisher	Scientific),	50 ng/mL	Tpo	




transferring	 the	cell	 suspension,	 the	wells	of	 the	culture	plates	were	washed	out	with	cell	
culture	medium	and	this	solution	was	added	to	the	cell	suspension.		
	












for	 approximately	 3	 hours.	 After	 starvation,	 half	 of	 each	 sample	 was	 stimulated	 with	
150ng/mL	Flt3L	 for	7.5	minutes.	The	same	volume	of	serum-free	 IMDM	was	added	to	the	
other	half	of	each	sample	(unstimulated	control).	All	samples	were	promptly	fixed	in	a	1.6%	








twice	 using	 2%	 FCS	DPBS	 before	 acquisition	 on	 a	 CyAN	 FACS	Analyser	 (Beckman	 Coulter)	






2.13.1			Plating	 of	 haematopoietic	 stem	 cells	 on	 MethoCult	
M3434	
	
For	 analysis	 of	 the	 survival	 and	 differentiation	 of	 HSCs,	 MethoCult	 M3434	 (StemCell	
Technologies,	 Cambridge,	 UK)	 was	 used.	 M3434	 contains	 50ng/mL	 recombinant	 mouse	















sorted	 into	 IMDM	 medium	 containing	 10%	 FCS,	 1,000 U/mL	 penicillin	 and	 1,000 μg/mL	










Colonies	 were	 identified	 by	 picking	 representative	 colonies	 with	 a	 10μL	 pipette	 tip,	




International,	 Lutterworth,	 UK)	 for	 centrifugation.	 Samples	were	 centrifuged	 at	 23g	 for	 8	
minutes	onto	microscope	slides	(Thermo	Fisher	Scientific)	and	then	air-dried.	Subsequently,	
cytospin	samples	were	stained	using	Diff-Quick	staining	solutions	(Polysciences,	Hirschberg	
an	der	Bergstrasse,	Germany).	 Samples	were	dipped	15	 times	 for	1	 second	 into	Solution1	
(Fixative),	Solution2	(Eosin	G)	and	then	Solution3	(Thiazine	dye),	before	being	washed	with	
distilled	water.	Square	cover	 slides	 (Agar	Scientific,	 Stansted,	UK)	were	mounted	onto	 the	

























progenitors	 were	 recognised	 as	 cells	 with	 pale	 blue	 cytoplasms,	 with	 high	 nuclear	 to	
cytoplasmic	ratio	(myeloblast)	and	dark	to	pale	pink	cytoplasms	(promyelocytes)	[300,	301].	
The	cytoplasm	of	promyelocytes	appears	 this	way	due	 to	 the	basophilic	nature	 (pale	blue	
staining)	 of	 the	 cytoplasm	 and	 magenta	 staining	 of	 cytoplasmic	 granules	 [300].	
Megakaryocytes	 and	 their	 progenitors	 were	 easily	 distinguished	 by	 their	 size.	
Promegakaryocytes	contain	granules	which	can	cause	pink/purple	staining	of	the	cytoplasm.	

































understanding	 of	HSPC	biology.	 For	 example,	 the	 LS−K	 compartment	 of	 the	murine	BM	 is	
commonly	divided	into	CMP,	GMP,	and	MEP	populations	using	the	CD16/32	and	CD34	surface	
markers	[67].	However,	Paul	et	al.	have	used	index	sorting	and	RNA-sequencing	to	identify	19	
subpopulations	 within	 the	 LS−K	 compartment,	 indicating	 that	 the	 above	 surface	 marker	
approach	does	not	accurately	capture	the	heterogeneity	of	myeloid	progenitors	[304].	Tsang	
et	 al.	 have	 also	 analysed	 RNA-sequencing	 data	 for	 single	 HSCs	 (LSK	 CD150+	 CD48−)	 and	
reported	 a	 large	 degree	 of	 transcriptional	 heterogeneity.	 The	 group	 found	 that	 genes	
associated	with	cell	cycle	activity,	protein	localisation	and	transcription	were	highly	variable	










LMPPs	 and	 HSCs	 in	 vivo,	 revealing	 a	 number	 of	 lineage-biased	 populations	 within	 each	
compartment.	A	number	of	HSC	and	LMPP	subpopulations	can	be	classified	based	on	their	
granulocyte,	 B-lymphocyte,	 DC	 and	 monocyte	 output	 [9,	 28].	 Similarly,	 Benz	 et	 al.	 have	
observed	 MyHSCs	 and	 LyHSCs	 when	 transplanting	 single	 HSCs	 into	 irradiated	 mice	 and	
monitoring	 their	 long-term	 output	 [309].	 These	 lineage-biased	 HSCs	 can	 also	 be	 isolated	
based	on	the	expression	of	particular	surface	or	 intracellular	markers.	The	Jacobsen	group	
have	identified	vWF+	HSCs	that	possess	increased	platelet	potential	in	vivo	when	compared	





to	 suggest	 that	HGFs	within	 the	BM	microenvironment	modulate	haematopoiesis	 through	
instructional	cues.	M-CSF	and	Epo	upregulate	lineage-associated	genes	in	early	HSPCs,	and	
stimulate	 them	 to	 differentiate	 towards	 a	 GM	 or	 erythroid	 fate,	 respectively	 [267,	 269].	
Similarly,	 Reiger	 et	 al.	 have	 shown	 that	 M-CSF	 and	 G-CSF	 are	 capable	 of	 instructing	 a	
macrophage	or	granulocytic	lineage	fate	in	single	GMPs	in	vitro,	respectively	[268].	There	is	










































Current	 evidence	 suggests	 that	 HSPCs	 are	 heterogeneous	 in	 regard	 to	 expression	 of	 the	
receptors	 for	Flt3L,	Epo,	M-CSF	and	G-CSF.	While	HSCs	have	been	shown	to	express	these	
receptors,	it	is	largely	unclear	whether	co-expression	of	these	HGF	receptors	is	commonplace	




model	 of	 haematopoiesis.	 On	 the	 other	 hand,	 if	 single	 HSCs	 and	 MPPs	 co-express	 HGF	
receptors,	this	would	support	a	deterministic	model	of	haematopoiesis	whereby	single	cells	
have	the	ability	to	respond	to	multiple	environmental	cues.	As	described	in	section	1.4,	there	























3.2			Investigation	 of	 FLT3,	 EPOR,	 CSF1R	 and	 CSF3R	




“a	 curated	 database	 of	 processed	 mRNA	 Gene	 expression	 profiles	 that	 provides	 an	 easy	
display	 of	 gene	 expression	 in	 haematopoietic	 cells”	 [296].	 The	 database	 provides	 gene	
expression	data	of	mouse	and	human	haematopoietic	cells,	including	data	for	human	acute	
myeloid	leukaemia,	from	271	microarray-based	experiments.	More	recently,	Bagger	and	co-





functionalities,	 such	 as	 graphical	 tree	 plots	 that	 illustrate	 how	 genes	 are	 differentially	
expressed	during	haematopoiesis	[297].	As	the	expression	of	FLT3,	EPOR,	CSF1R	and	CSF3R	
by	mouse	HSPCs	was	of	 interest,	the	expression	data	for	these	particular	genes	within	the	








pre-B-lymphocyte	 and	 ETP	 populations.	 The	 available	 information	 regarding	 the	 surface	









some	 populations,	 so	 statistical	 analysis	 could	 not	 be	 performed	 for	 these	 samples.	
Additionally,	as	can	be	seen	in	Figure	3.1,	the	data	obtained	from	the	databases	show	that	













batch	 effect	 estimators	 so	 that	 results	 can	 be	 compared	 across	 the	 numerous	 studies	
compiled	within	the	databases.	Targets	were	amplified	in	all	populations,	suggesting	that	the	




cell;	 ST-HSC,	 short-term	 haematopoietic	 stem	 cell;	 LMPP,	 lymphoid-primed	 multipotent	
progenitor;	preGM,	pre-granulocyte-macrophage	progenitor;	GMP,	granulocyte-macrophage	
progenitor;	 MEP,	 megakaryocyte-erythroid	 progenitor;	 EP,	 erythroid	 progenitor;	 MkP,	





























and	MEP).	 This	 is	 commensurate	with	 the	 known	 association	 of	EPOR	with	 the	 erythroid	
lineage.	LMPPs	are	known	to	lack	expression	of	erythroid	related	genes	[73],	and	the	levels	of	














[p=0.3427],	MkPs	 [p=0.495]	 and	 Pro-B-lymphocytes	 [p=0.29],	 indicating	 that	 the	 levels	 of	

























ST-HSC,	 short-term	 haematopoietic	 stem	 cell;	 LMPP,	 lymphoid	 primed	 multipotent	
progenitor;	preGM,	pre-granulocyte-macrophage	progenitor;	GMP,	granulocyte-macrophage	
progenitor;	 MEP,	 megakaryocyte-erythroid	 progenitor;	 EP,	 erythroid	 progenitor;	 MkP,	
megakaryocyte	 progenitor;	 CFU-E,	 erythroid	 colony	 forming	 unit;	 CLP,	 common	 lymphoid	










potential,	 such	 as	 LMPPs,	 preGMs	 and	 GMPs.	 Interestingly,	 the	 highest	 level	 of	 CSF3R	
expression	was	found	to	be	in	the	ST-HSC	compartment.	However,	statistical	analysis	was	not	
performed	on	 this	population	as	 the	data	 included	 just	2	data	points.	Again,	 low	 levels	of	
CSF3R	expression	by	MEPs,	CFU-Es,	preCFU-Es	and	EPs	indicated	amplification	due	to	gDNA,	
implying	 that	 these	 populations	 did	 not	 express	 the	 CSF3R	 gene.	 LT-HSCs	 expressed	
significantly	lower	levels	of	CSF3R	than	LMPPs	[p=0.0317]	but	significantly	higher	levels	than	






these	 receptors	 by	 cells	 at	 later	 stages	 of	 development	 is	 largely	 restricted	 to	 progenitor	











3.3			Gating	 strategy	 for	 the	 isolation	 and	 analysis	 of	
haematopoietic	stem	and	progenitor	cells	
	
In	 order	 to	 analyse	 the	 patterns	 of	 HGF	 receptor	 expression	 during	 haematopoiesis,	 flow	
cytometry	antibody	panels	were	designed	for	the	identification	and	isolation	of	HSPCs.	The	
cell	 surface	 marker	 profiles	 were	 adapted	 from	 recent	 publications	 (Figure	 3.2).	 When	









Kit,	 the	 early	 HSPC	 populations	 could	 be	 identified.	 Within	 the	 LSK	 compartment,	 the	
Morrison	group	has	shown	that	CD150	and	CD48	allow	for	the	enrichment	of	HSCs,	MPPs	and	
progenitors	with	varying	lineage-potentials	[34].	Therefore,	this	gating	strategy	was	employed	
to	 identify	 HSCs	 and	MPPs	 as	 LSK	 CD150+	 CD48−	 and	 LSK	 CD150−	 CD48−	 respectively.	 To	
















kinase	 3;	 IL-7R,	 interleukin-7	 receptor;	 HSC,	 haematopoietic	 stem	 cell;	 MPP,	 multipotent	
progenitor;	 HPC,	 haematopoietic	 progenitor	 cell;	 LMPP,	 lymphoid-primed	 multipotent	
progenitor;	 CLP,	 common	 lymphoid	 progenitor;	 CMP,	 common	myeloid	 progenitor;	 GMP,	











































































maturing	 progenitors,	 such	 as	 HPC-1	 (LSK	 CD48+	 CD150−),	 which	 possesses	 GM-lymphoid	
potential	and	minimal	MegE	potential,	and	HPC-2	(LSK	CD48+	CD150+),	a	population	that	can	
give	rise	to	MegE	cells	and	very	few	GM-lymphoid	cells	[34].	However,	as	some	HPC-1	are	






















cells	 were	 gated	 according	 to	 FSC/SSC	 and	 pulse	 width.	 BM,	 bone	 marrow;	 AF,	 auto-
fluorescence;	 LS−K,	 Lineage−	 Sca1−	 c-Kit+;	 LSK,	 Lineage−	 Sca1+	 c-Kit+;	 Flt3,	 fms-like	 tyrosine	
kinase	3;	IL-7Rα,	interleukin-7	receptor	α	subunit;	HSC,	haematopoietic	stem	cell;	LT,	 long-
term;	 ST,	 short-term;	MPP,	 multipotent	 progenitor;	 HPC,	 haematopoietic	 progenitor	 cell;	
LMPP,	 lymphoid-primed	multipotent	progenitor;	CLP,	common	 lymphoid	progenitor;	CMP,	












surface	 [67].	As	 such,	myeloid	progenitors	were	 identified	by	gating	 for	 LS−K	 IL-7Rα−	cells.	
Within	this	compartment,	expression	of	CD16/32	and	CD34	was	used	to	identify	CMPs	(LS−K	
IL-7Rα−	 CD16/32lo	 CD34hi),	 GMPs	 (LS−K	 IL-7Rα−	 CD16/32hi	 CD34hi)	 and	MEPs	 (LS−K	 IL-7Rα−	






























term	 haematopoietic	 stem	 cell;	 ST-HSC,	 short-term	 haematopoietic	 stem	 cell;	 LMPP,	
lymphoid-primed	multipotent	progenitor;	preGM,	pre-granulocyte-macrophage	progenitor;	
GMP,	granulocyte-macrophage	progenitor;	MEP,	megakaryocyte-erythroid	progenitor;	MkP,	












significant	 differences	 in	 the	 expression	 of	 ACTB	 between	 a	 number	 of	 populations.	 For	
example,	 the	 levels	 of	 ACTB	 expressed	 by	 ST-HSCs	 was	 significantly	 higher	 than	 LMPPs	
[p=0.0342],	 GMPs	 [p=0.0226]	 and	 MEPs	 [p=0.0146].	 This	 indicated	 that	 analysing	 HGF	















Csf1r	 and	 Csf3r	 transcripts	 were	 designed.	 Each	 gene	 was	 examined	 using	 the	 Ensembl	
genome	 browser	 (FLT3,	 ENSMUSG00000042817;	 EPOR,	 ENSMUSG00000006235;	 CSF1R,	
ENSMUSG00000024621;	CSF3R,	ENSMUSG00000028859)	to	determine	the	sequences	of	all	








mouse	 genome.	 BLAST	 analysis	 revealed	 that	 no	 pseudogenes	 containing	 the	 sequence	
spanning	the	junction	between	the	first	and	second	exon	in	the	murine	ACTB	gene	exist,	so	


















































Assay/Target	 Forward	Primer	 Reverse	Primer	 Hydrolysis	Probe	
ACTB	 5’-CAGCTTCTTTGCAGCTCCTTC-3’	 5’-CGACCAGCGCAGCGATAT-3’	 5’-CACCAGTTCGCCATGGA-3’	
FLT3	 5’-ATCAGCGGGAAAGCCATCATC-3’	 5’-GGGCACACTGGAGGTCTTCT-3’	 5’-TCCTCGCACCATTCGGTA-3’	
EPOR	 5’-CATACCAGCTCGAGGGTGAGTCAC-3’	 5’-CTCCGGGATGGACTTCAACTAC-3’	 5’-CTGGTGCAGGCTACATGACT-3’	
CSF1R	 5’-ACCTGTCCTGGTCATCACT-3’	 5’-AACCTCTTGGGAGCCTGTACTCAC-3’	 5’-GCATAGCCTCGGCCTTCCTT-3’	
CSF3R	 5’-TGGACACATCGAGATTTCAC-3’	 5’-CTGCACCCTGACTGGAGTTAC-3’	 5’-GTGCAAGAGGCCAGGACAG-3’	






Csf3r	 transcripts	were	designed	 to	 flank	each	corresponding	exon-exon	 junction	using	 the	
RealTimeDesign	Software	(described	in	Section	2.8).	Where	possible,	a	probe	was	designed	







transcripts	 were	 purchased	 from	 Biosearch	 Technologies	 (California,	 USA)	 and	 DNA	
Technology	(Aarhus,	Denmark).	Primer	and	hydrolysis	probe	sequences	for	the	ACTB,	FLT3,	
EPOR,	CSF1R	and	CSF3R	qRT-PCR	assays	are	listed	in	Table	8.		
3.4.3			Optimisation	 of	 ACTB,	 FLT3,	 EPOR,	 CSF1R	 and	 CSF3R	
qRT-PCR	assays	
	
Next,	 the	 specificity	 of	 the	 ACTB,	 FLT3,	 EPOR,	 CSF1R	 and	 CSF3R	 qRT-PCR	 assays	 was	
confirmed.	As	these	assays	were	designed	for	the	detection	of	mRNA,	they	were	tested	to	
ensure	 they	 did	 not	 amplify	 gDNA.	 To	 do	 this,	 qRT-PCR	 analysis	 of	whole	 BM	 lysate	was	


















and	 probe	 concentrations	 needed	 to	 be	 optimised.	 The	 use	 of	 limiting	 concentrations	 of	




Optimum	 primer	 concentrations	 were	 determined	 for	 each	 qRT-PCR	 assay	 by	 comparing	



















Csf3r	 from	 whole	 BM	 samples	 with	 (red	 amplification	 curves)	 and	 without	 (green	
amplification	curves)	RT.	Fluorescence	is	plotted	on	a	log	scale.	BM,	bone	marrow;	RT,	reverse	
transcriptase.	ACTB,	β-actin;	FLT3,	fms-like	tyrosine	kinase	3;	EPOR,	erythropoietin	receptor;	

















































































Figure 3.6. Ct values obtained during primer
optimisation of qRT-PCR assays. Primers of the ACTB,
FLT3, EPOR, CSF1R and CSF3R qRT-PCR assays were
tested in varying concentrations and combinations to
determine limiting conditions. Grey transparent
panes are set to 0.5 cycles greater than the Ct of the
reference reaction (300nM forward primer, 300nM
reverse primer). All reactions with a Ct value above
this were considered to have maintained efficiency
when compared to the reference reaction (note z-axis
is in reverse). Each data point represents the mean of
3 technical replicates. Ct, threshold cycle; ACTB, β-
actin; FLT3, fms-like tyrosine kinase 3; EPOR,
erythropoietin receptor; CSF1R, macrophage-colony
stimulating factor receptor; CSF3R, granulocyte-


















































Figure 3.7. Peak fluorescence obtained during
primer optimisation of qRT-PCR assay. Primers of
the ACTB, FLT3, EPOR, CSF1R and CSF3R qRT-PCR
assays were tested in varying concentrations and
combinations to determine limiting conditions.
Fluorescence values at the end of the plateau
phase were plotted for each primer combination.
Each data point represents the mean of 3 technical
replicates. AU, arbitrary units; ACTB, β-actin; FLT3,
fms-like tyrosine kinase 3; EPOR, erythropoietin
receptor; CSF1R, macrophage-colony stimulating





This	method	was	 successful	 for	 the	ACTB,	 FLT3,	 EPOR	 and	 CSF3R	 assays.	 However,	when	
analysing	the	CSF1R	primer	optimisation	data,	all	of	the	primer	combinations	that	resulted	in	
a	Ct	value	of	<0.5	cycles	greater	 than	 the	 reference	 reaction	Ct	value	had	either	equal	or	
greater	 end	 fluorescence	 values.	 Even	minor	 decreases	 in	 peak	 fluorescence	 values	were	
accompanied	 by	 an	 increase	 in	 Ct	 values	 (Figure	 3.6	 and	 Figure	 3.7).	 Thus,	 the	 primer	




the	 ACTB,	 FLT3,	 EPOR,	 CSF1R	 and	 CSF3R	 qRT-PCR	 assays	 were	 subsequently	 optimised.	
Reactions	were	set	up	using	varying	concentrations	of	hydrolysis	probe	to	amplify	a	constant	
concentration	of	 template	 (approximately	200ng	of	RNA	and	DNA	from	whole	BM	 lysate).	
Again,	 a	 detailed	 protocol	 is	 described	 in	 Section	 2.8.	 A	 reaction	 containing	 250nM	 of	




efficiency,	 the	 lowest	 concentration	 of	 probe	 was	 selected	 as	 the	 optimal	 probe	
concentration	(Figure	3.8).	Probe	optimisation	was	successful	for	all	of	the	assays.	Therefore,	
the	ACTB,	FLT3,	EPOR,	CSF1R	and	CSF3R	qRT-PCR	assays	were	fully	optimised,	and	all	future	
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doubling.	 Common	 lymphoid	 progenitors,	 lymphoid-primed	 multipotent	 progenitors,	
erythroid	progenitors	and	CD115+	 leukocytes	were	sorted	 to	 test	 the	efficiency	of	 the	 (A)	
ACTB,	(B)	FLT3,	(C)	EPOR	and	(D)	CSF1R	qRT-PCR	assays,	respectively.	Data	represents	mean	
±	standard	error	 from	at	 least	3	samples.	Ct,	 threshold	cycle;	ACTB,	β-actin;	FLT3,	 fms-like	



































ACTB	 60	 300	 125	 Yes	
FLT3	 80	 60	 225	 Yes	
EPOR	 80	 100	 150	 Yes	
CSF1R	 300	 300	 125	 Yes	
CSF3R	 300	 60	 175	 No	




Using	 the	 ACTB,	 FLT3,	 EPOR	 and	 CSF1R	 qRT-PCR	 assays,	 expression	 of	 the	 respective	
transcripts	 in	 single	 cells	were	 successfully	 detected.	On	 average,	 a	 decrease	 of	 1	 Ct	was	







that	 the	CSF3R	assay	was	not	 sensitive	when	assaying	 single	cells	 (Figure	3.11).	Thus,	 this	
assay	was	not	used	to	analyse	CSF3R	expression	in	HSPCs	in	future	experiments.	The	ability	








did	 not	 efficiently	 amplify	 Csf1r	 transcripts	 when	 analysing	 single	 Ly6G+	 neutrophils.	 The	











































multipotent	 progenitor;	 EP,	 erythroid	 progenitor;	 Ct,	 threshold	 cycle;	ACTB,	 β-actin;	FLT3,	
fms-like	 tyrosine	 kinase	 3;	 EPOR,	 erythropoietin	 receptor;	 CSF1R,	 macrophage-colony	
stimulating	factor	receptor.	
	











































































and	 efficiencies	were	 tested	 as	 before.	One	 reaction	 combined	 the	ACTB,	FLT3	and	EPOR	
assays	(ACTB	+	FLT3	+	EPOR	triplex	qRT-PCR	assay),	and	a	second	combined	the	ACTB	+	EPOR	




ACTB	 +	 EPOR	 +	CSF1R	 triplex	 qRT-PCR	 assay	was	 tested	 by	 sorting	 both	 EPs	 and	 CD115+	
leukocytes	into	the	same	wells	of	a	PCR	plate.		
	
Unfortunately,	while	 the	Ct	values	 for	 the	ACTB	+	FLT3	+	EPOR	and	ACTB	+	EPOR	+	CSF1R	
triplex	 reactions	were	 comparable	 to	 singleplex	 reactions	 (Figure	 3.13),	 the	 amplification	
curves	of	the	assays	in	triplex	showed	a	loss	in	efficiency	of	at	least	one	of	the	assays	(Figure	
3.14	and	Figure	3.15).	As	this	may	cause	issues	when	assaying	cells	with	a	very	low	level	of	
gene	expression,	all	HSPCs	were	 first	assayed	 for	HGF	gene	expression	of	FLT3,	EPOR	 and	
















point	 represents	mean	±	 standard	error	 from	at	 least	 3	 samples.	 LMPP,	 lymphoid	primed	
multipotent	 progenitor;	 EP,	 erythroid	 progenitor;	 SP,	 singleplex;	 TP,	 triplex;	 Ct,	 threshold	
cycle;	ACTB,	β-actin;	FLT3,	fms-like	tyrosine	kinase	3;	EPOR,	erythropoietin	receptor;	CSF1R,	
macrophage-colony	stimulating	factor	receptor.	









































































































Figure	 3.15.	 Amplification	 of	 Actb,	 Epor	 and	 Csf1r	 in	 single	 cells	 using	 triplex	 qRT-PCR	
reactions.	Comparison	of	amplification	of	Actb,	Epor	and	Csf1r	 in	varying	numbers	of	cells	
using	 singleplex	 reactions	 to	 triplex	 reactions.	 The	 EPOR	 and	 CSF1R	 qRT-PCR	 assays	 lost	







3.5			Expression	 of	 growth	 factor	 receptor	 transcripts	
during	haematopoiesis	
	




the	 expression	 of	 FLT3,	 EPOR	 and	 CSF1R	 genes	 within	 HSPC	 populations.	 For	 single	 cell	
analysis,	cells	from	3-6	mice	were	analysed	and	approximately	20-40	cells	were	obtained	from	
each	mouse.	As	such,	all	data	from	this	section	are	represented	in	two	ways;	i)	percentages	

















LT-HSCs	 that	 were	 analysed,	 11.6%	 ±	 2.19	 (28/248	 cells;	 11.3%	 of	 total)	 expressed	 Flt3	
transcripts,	and	21%	±	3.4	of	cells	in	the	ST-HSC	compartment	(56/252	cells;	22.2%	of	total)	
also	expressed	this	gene.	There	was	a	significant	increase	in	the	number	of	FLT3	expressing	
cells	 in	 the	 ST-HSC	 population	when	 compared	 to	 the	 LT-HSC	 population	 [p=0.0476].	 The	
number	of	cells	within	the	MPP	(n=6	mice)	compartment	expressing	FLT3	(64%	±	2.2	of	cells;	





























compartments	were	detected,	and	 these	values	 reflect	previous	 findings	 [115,	320].	EPOR	
was	expressed	by	12.8%	±	1.46	 (31/245	 cells;	 12.7%	of	 total)	 of	 LT-HSCs	and	19.3%	±	4.6	
(42/237	cells;	17.7%	of	total)	of	ST-HSCs,	and	these	values	were	not	significantly	different	[p=	
0.2188].	 Of	 the	MPPs	 (n=6	mice)	 analysed,	 only	 8.2%	 ±	 4.6	 (25/300	 cells;	 8.3%	 of	 total)	
expressed	EPOR.	While	 this	was	 lower	 than	 the	number	 of	 ST-HSCs	 expressing	EPOR,	 the	
difference	was	not	significant	[p=0.0628]	(Figure	3.17B).		
	




cells	were	due	 to	 impurities	during	 sorting.	However,	 as	M-CSF	 is	 known	 to	 instruct	HSCs	
towards	myeloid	fates	by	stimulating	its	receptor,	CSF1R	expression	would	be	expected	in	this	
compartment	[267].	The	qRT-PCR	assay	used	here	may	not	have	been	sensitive	enough	to	
















LT-HSC	 248	 248	 100	 258	 245	 94.96	 122	 122	 100	
ST-HSC	 269	 252	 93.68	 266	 237	 89.10	 122	 118	 96.72	
MPP	 305	 297	 97.38	 306	 300	 98.04	 151	 145	 96.03	
HPC1	 101	 101	 100	 104	 100	 96.15	 101	 101	 97.12	
HPC2	 58	 56	 96.55	 59	 58	 98.31	 57	 56	 98.25	
LMPP	 99	 97	 97.98	 99	 99	 100	 99	 97	 97.98	
CLP	 95	 94	 98.95	 97	 94	 96.91	 91	 90	 98.90	
CMP	 86	 81	 94.19	 87	 79	 90.80	 88	 81	 92.05	
GMP	 102	 98	 96.08	 102	 96	 94.12	 104	 99	 95.19	
MEP	 102	 92	 90.20	 102	 98	 96.08	 102	 96	 94.12	
LT-HSC,	long-term	haematopoietic	stem	cell;	ST-HSC	short-term	haematopoietic	stem	cell;	MPP,	multipotent	progenitor;	HSPC,	haematopoietic	






Next,	 the	 expression	 of	 FLT3,	 EPOR	 and	 CSF1R	 by	 more	 mature	 BM	 progenitors	 was	
investigated,	 and	 the	 analysis	 revealed	 a	 clear	 association	 between	 the	 presence	 of	 HGF	
receptor	 transcripts	 and	 the	 lineage	potential	 of	 the	populations.	A	 large	number	of	 cells	




66%	 of	 total)	 expressed	 FLT3.	 Again,	 given	 that	 CLPs	 are	 regulated	 by	 Flt3L	 this	 was	 not	
surprising	[321].	When	Flt3−/lo	HPC-1	(n=3	mice)	were	analysed,	57.2%	±	14.1	(57/101	cells;	
56.4%	of	total)	of	cells	expressed	FLT3.	The	number	of	cells	that	expressed	FLT3	significantly	




























stem	 and	 progenitor	 cell;	 HPC,	 haematopoietic	 progenitor	 cell;	 LMPP,	 lymphoid-primed	
multipotent	 progenitor;	 CLP,	 common	 lymphoid	 progenitor;	 CMP,	 common	 myeloid	

























































































































































cells	 [7.14%	of	 total]).	CSF1R	 expression	was	not	detected	 in	 any	of	 the	MEPs	 (n=3	mice)	
















population	 (Mean	 Ct:	 36.24)	 [p=0.0039].	 As	 the	 HPC-2	 population	 largely	 contains	 MegE	
primed	progenitors	 [34],	 this	was	expected	 (Figure	3.18A).	 Lastly,	 the	mean	expression	of	












and	 Epor+	 ST-HSCs	 [p=0.3161].	 Additionally,	 while	 Epor+	MPPs	 (Mean	 Ct:	 33.1)	 expressed	








revealed	 the	 varying	 levels	 of	 erythroid	 potential	 possessed	 by	 cells	 within	 the	 MPP	
population	 [324].	Additionally,	analysis	of	PU.1	and	GATA-1	expression	 in	MPPs	using	GFP	
transgenic	mice	allows	for	the	purification	of	PU.1+	and	GATA-1+	LSK	CD34+	that	are	lymphoid-	
and	MegE-primed,	 respectively	 [325].	 Thus,	 it	 is	 possible	 that	 the	 large	 variation	 in	EPOR	



















HSC	 short-term	 haematopoietic	 stem	 cell;	 MPP,	 multipotent	 progenitor;	 HSPC,	
haematopoietic	 stem	 and	 progenitor	 cell;	 HPC,	 haematopoietic	 progenitor	 cell;	 LMPP,	
lymphoid-primed	multipotent	progenitor;	CLP,	common	lymphoid	progenitor;	CMP,	common	
myeloid	 progenitor;	 GMP,	 granulocyte-macrophage	 progenitor;	 MEP,	 megakaryocyte-













was	 lower	 than	 the	 level	 expressed	 by	 Csf1r+	 LMPPs	 (Mean	 Ct:	 35.17),	 but	 this	 was	 not	
significant	 [p=0.0804].	However,	when	compared	 to	 the	Csf1r+	CMP	population	 (Mean	Ct:	
33.91),	 Csf1r+	 MPPs	 expressed	 significantly	 lower	 mean	 levels	 of	 CSF1R	 [p=0.0055].	
Furthermore,	the	mean	levels	of	CSF1R	expressed	by	Csf1r+	GMPs	(Mean	Ct:	31.9)	was	very	
significant	 when	 compared	 to	 the	 levels	 expressed	 by	 the	 Csf1r+	 CMP	 compartment	
[p<0.0001].	 The	 Csf1r+	 Flt3−/lo	 HPC-1	 (Mean	 Ct:	 36.1)	 and	 Csf1r+	 CLP	 (Mean	 Ct:	 35.92)	
populations	expressed	the	lowest	mean	levels	of	CSF1R.	Considering	that	the	CLP	and	HPC-1	
populations	are	 largely	 lymphoid-primed	progenitors,	 this	was	not	surprising.	Single	Csf1r+	
MPPs	and	Flt3−/lo	HPC-1	expressed	levels	of	CSF1R	that	differed	by	up	to	3	doublings,	or	8-




3.5.2			Analysis	 of	 FLT3	 and	 EPOR	 co-expression	 within	 the	













Unfortunately,	 as	 described	 in	 Section	 3.4.3,	 the	 efficiency	 of	 the	 FLT3	 qRT-PCR	 assay	
decreased	when	 it	was	 combined	 in	 a	multiplex	 reaction	with	 the	ACTB	and	EPOR	 assays	













As	 before,	 the	 EPOR-2	 qRT-PCR	 assay	 was	 tested	 and	 optimised	 to	 ensure	 efficient	
amplification	of	gene	targets.	Analysis	showed	that	it	was	specific	for	Epor	mRNA,	and	did	not	
detect	gDNA	(Figure	3.20A).	The	assay	conditions	were	optimised	as	before,	and	the	optimum	

















































































































































FLT3	 assays,	 the	 three	 assays	 were	 tested	 in	 triplex	 using	 single	 cells.	 As	 before,	 varying	
numbers	of	LMPPs	and	EPs	were	sorted	 into	wells	of	a	PCR	plate,	and	the	qRT-PCR	assays	
were	tested	 individually	and	 in	 triplex	 (Figure	3.21	and	Figure	3.22).	When	comparing	the	
























that	 are	 present	 in	 the	 sample,	 respectively.	 Cell	 number	 values	 for	 the	ACTB	 assay	 are	
representative	 of	 the	 number	 of	 LMPPs	 and	 EPs	 that	 are	 present	 in	 the	 sample.	 Data	
represents	 mean	 ±	 standard	 mean	 from	 at	 least	 3	 samples.	 LMPP,	 lymphoid-primed	


































shows	 the	absolute	number	of	ST-HSCs	 that	did	not	express	FLT3	or	EPOR	 (clear	column),	
expressed	either	FLT3	or	EPOR	exclusively	(shaded	column),	or	co-expressed	both	FLT3	and	
EPOR	 (black	column).	Reactions	were	carried	out	 in	triplex	with	an	assay	specific	 for	ACTB	
expression.	Data	in	(A)	are	the	mean	±	standard	error	of	the	values	obtained	for	single	cells	
from	3-6	mice.	p	values	 in	 (B)	obtained	by	McNemar’s	 test	where;	**,	p	<	0.01;	****,	p	<	





































































































































while	the	other	cell	expressed	relatively	 low	 levels	of	FLT3	and	EPOR	 (Figure	3.25).	Of	 the	









that	 these	 positive	 events	were	 due	 to	 the	 presence	 of	more	 than	 one	 cell	 in	 the	wells.	
However,	the	parameters	of	the	sorting	experiments	were	modified	to	minimalise	the	chance	
of	sorting	doublets.	Firstly,	the	drop	envelope	was	set	to	0.5	during	sorting.	Secondly,	as	the	
ST-HSCs	were	 initially	 sorted	 into	 an	 Eppendorf	 before	 being	 sorted	 into	 PCR	 plates,	 the	
secondary	 single	 cell	 isolation	 sort	 rate	was	 very	 slow	 (from	observation).	 Finally,	 as	 cells	
expressing	FLT3	or	EPOR	represent	such	a	small	number	of	ST-HSCs	(approximately	21%	and	
19%,	 respectively),	 if	 these	 genes	were	 expressed	 exclusively,	 the	 likelihood	 of	 a	 doublet	
event	being	due	 to	a	Flt3+	ST-HSC	and	a	Epor+	ST-HSC	 is	 small	 (3.99	 in	100).	Ultimately,	 it	
impossible	 to	 determine	whether	 the	 amplification	 of	Flt3	 and	Epor	 in	 a	well	was	 due	 to	






















cells	 that	were	purified	 from	n=3	mice.	Gene	expression	 is	 depicted	 in	 Ct	 values.	 ST-HSC,	























3.6			Expression	 of	 growth	 factor	 receptor	 protein	
during	haematopoiesis	
	











Flow	 cytometry	 antibodies	 specific	 for	 Flt3	 (CD135)	 and	 M-CSFR	 (CD115)	 were	 readily	
available,	as	they	had	been	used	to	isolate	cells	for	qRT-PCR	assay	optimisation	and	analysis	
of	HGF	receptor	gene	expression.	However,	sourcing	a	commercial	antibody	specific	for	EpoR	

























Figure	 3.26.	 Specificity	 of	 anti-G-CSFR	 antibody	 after	 APC	 conjugation.	 A	 commercially	
available	 purified	 anti-G-CSFR	 (CD114)	 antibody	 was	 purchased	 and	 conjugated	 with	 the	
fluorophore,	APC.	Whole	BM	was	stained	with	the	conjugated	anti-G-CSFR	antibody	and	an	
anti-Ly6G	 antibody	 to	 identify	 granulocytes.	 As	 Ly6G	 stains	 granulocytes,	 it	 was	 used	 to	




























control	 (shaded	 histogram).	 Percentages	 of	 cells	within	 the	 given	 population	 that	 stained	
positive	for	the	HGF	receptors	are	depicted	in	the	upper	right	corner	of	each	histogram.	Data	
are	 the	mean	 ±	 standard	 error	 of	 values	 obtained	 from	 n	 =	 3-6	mice.	 LT-HSC,	 long-term	
haematopoietic	 stem	cell;	 ST-HSC	 short-term	haematopoietic	 stem	cell;	MPP,	multipotent	
progenitor;	 HPC,	 haematopoietic	 progenitor	 cell;	 LMPP,	 lymphoid-primed	 multipotent	
progenitor;	 CLP,	 common	 lymphoid	 progenitor;	 CMP,	 common	myeloid	 progenitor;	 GMP,	


























































LT-HSC ST-HSC MPP Flt3-/lo HPC-1 HPC-2




Firstly,	 the	presence	of	Flt3	protein	within	 the	HSC	compartment	was	 investigated	 (Figure	
3.28A).	 Low	 levels	 of	 surface	 Flt3	 expression	were	 consistently	 detected	 on	 LT-HSCs	 (n=6	
mice)	 (4.6%	 ±	 1).	 There	 was	 a	 slight	 increase	 in	 Flt3	 expression	 within	 the	 ST-HSC	
compartment	 (n=6	mice)	 (7.7%	 ±	 1.2)	when	 compared	 to	 LT-HSCs,	 although	 this	was	 not	
significant	[p=0.1797].	For	each	experiment,	the	gating	was	set	according	to	the	Flt3	isotype	
control	 samples.	When	 setting	 the	 gates,	 the	 Flt3+	 values	 for	 LT-HSCs	 and	 ST-HSCs	 in	 the	
isotype	control	samples	(n=2)	only	accounted	for	0.59%	±	0.37	and	0.45%	±	0.07,	respectively,	
indicating	that	levels	of	Flt3	observed	in	the	HSC	compartment	were	due	to	staining	of	Flt3	
protein.	 The	number	of	 cells	 expressing	 Flt3	within	 the	HSC	 compartments	was	 similar	 to	
previously	published	findings.	The	Jacobsen	group	has	reported	that	Flt3	 is	present	on	the	
surface	 of	 approximately	 6%	 of	 LSK	 CD150+	 CD48−	 cells	 [323].	 Similarly,	 Chu	 et	 al.	 have	
reported	that	Flt3	is	present	on	the	surface	of	<5%	of	LSK	CD150+	CD48−	cells	[329].	While	a	
value	was	not	included	in	the	article,	Oguro	et	al.	detected	a	small	number	of	HSC-1	and	HSC-















stem	cell;	 ST-HSC	 long-term	haematopoietic	 stem	cell;	MPP,	multipotent	progenitor;	HPC,	
haematopoietic	 progenitor	 cell;	 LMPP,	 lymphoid-primed	 multipotent	 progenitor;	 CLP,	
common	 lymphoid	 progenitor;	 CMP,	 common	 myeloid	 progenitor;	 GMP,	 granulocyte-








[34].	 As	 the	 LMPP	 (n=6	mice)	 population	 is	 distinguished	 as	 Flt3hi,	 all	 of	 the	 cells	 in	 this	
population	 were	 Flt3+	 (100%	 ±	 0).	 Conversely,	 the	 number	 of	 Flt3	 expressing	 cells	 was	














(80.4%	 ±	 2.1),	 and	 this	 was	 significantly	 higher	 when	 compared	 to	 the	 MPP	 population	
[p=0.0022].	Within	the	Flt3−/lo	HPC-1	(n=6)	compartment,	58.6%	±	3	of	cells	were	Flt3+,	while	












the	 IL-7Rα	 antibody	 and	 the	 shaded	 histograms	 depict	 the	 isotype	 control.	 HSC,	
haematopoietic	 stem	cell;	 Lin,	 lineage	markers;	Flt3,	 fms-like	 tyrosine	 kinase	3;	 BM,	bone	
marrow;	IL-7Rα,	interleukin-7	receptor	α	subunit.	
	





















there	was	a	decrease	 in	 the	number	of	cells	expressing	M-CSFR	as	cells	committed	 to	 the	
lymphoid	lineage,	as	only	4.12%	±	0.3	of	the	CLP	(n=6	mice)	population	were	M-CSFR+	(Figure	
3.28B).	 Conversely,	 there	 was	 an	 increase	 in	 the	 number	 of	 M-CSFR+	 cells	 as	 cells	
differentiated	 towards	 the	myelomonocytic-granulocytic	 lineages.	When	 compared	 to	 the	
MPP	population,	the	HPC-2	compartment	(n=6)	(27.1%	±	4.4)	contained	significantly	more	M-
CSFR+	cells	[p=0.0313].	Additionally,	there	was	an	increase	in	the	number	of	cell	express	M-
CSFR	 in	 the	CMP	population	 (n=3)	 (27%	±	0.8)	when	compared	 to	MPPs,	but	 this	was	not	
significant	[p=0.25].	Furthermore,	the	GMP	compartment	(n=3)	(50.2%	±	2.12)	contained	the	
highest	fraction	of	M-CSFR+	cells	when	compared	to	all	other	populations.	Virtually	all	MEPs	
















detectable	 levels	 of	 FLT3	 when	 analysed.	 For	 the	 other	 populations,	 the	 number	 of	 cells	
expressing	Flt3	protein	or	Flt3	transcripts	were	similar.	For	example,	63.65%	±	3	(n=6)	of	MPPs	
expressed	 Flt3	on	 their	 surface,	 and	64%	±	2.2	 (n=6)	 expressed	detectable	 levels	 of	FLT3.	








3.6.2			Investigation	 of	 Flt3	 and	 M-CSFR	 co-expression	 by	
haematopoietic	stem	cells	and	multipotent	progenitors	
	
Both	 Flt3	 and	 M-CSFR	 were	 detected	 on	 the	 surface	 of	 LT-HSCs,	 ST-HSCs	 and	 MPPs.	 As	












Flt3	and	M-CSFR	on	 the	 surface	of	HSCs	 (LSK	CD150+	CD48−).	 (B)	Staining	profiles	of	HSCs	
stained	with	the	Flt3	(left)	or	M-CSFR	(right)	isotype	controls.	Values	displayed	represent	the	
percentage	of	HSCs	within	the	given	gate.	HSC,	haematopoietic	stem	cell;	LSK,	Lineage−	Sca1+	
c-Kit+;	 Flt3,	 fms-like	 tyrosine	 kinase	 3;	 M-CSFR,	 macrophage-colony	 stimulating	 factor	
receptor.	
	
















































that	also	express	Flt3	on	 their	 surface	 is	depicted.	Data	are	 the	mean	±	 standard	error	of	
values	 obtained	 from	n	 =	 6	mice.	p	 values	were	 obtained	 by	 performing	 two-tailed	 non-




When	 compared	 to	 Flt3+	 ST-HSCs,	 there	 was	 a	 decrease	 in	 the	 number	 of	 Flt3+	 MPPs	
expressing	M-CFR	(14.46%	±	2.62)	[p=0.0313].	This	decrease	can	be	explained	by	the	large	

































































increased	 to	 11.52%	 ±	 1.71	 when	 analysing	 the	 M-CSFR+	 ST-HSCs	 population	 [p=0.0313]	
(Figure	3.31C).	There	was	 large	 increase	 in	M-CSFR+	MPPs	expressing	Flt3	 (69.17%	±	3.29)	


























Figure	 3.32.	 Expression	 of	 Flt3	 and	 M-CSFR	 within	 the	 LT-HSC,	 ST-HSC	 and	 MPP	
compartments.	The	(A)	LT-HSC,	(B)	ST-HSC	and	(C)	MPP	populations	were	divided	into	cells	











of	 CD150	 expressed	 on	 the	 surface	 of	 haematopoietic	 stem	
cells	
	
HSCs	 are	 routinely	 subdivided	 into	 functionally	 distinct	 compartments	 based	 on	 the	
expression	of	particular	surface	and	cytoplasmic	markers.	Varying	levels	of	CD150	expression	
have	been	used	 to	divide	HSCs	 into	CD150	high	 (CD150hi)	myeloid-biased	cells	and	CD150	
intermediate	(CD150int)	cells,	which	possess	less	self-renewal	capacity	and	MegE	potential	in	






















cells).	 This	was	 considered	 too	 few	 for	 accurate	 analysis,	 so	 the	 correlation	 between	 the	







cells	were	 gated	when	 analysing	 Flt3	 and	M-CSFR	 expression	 on	 the	 surface	 of	 HSCs.	 (A)	
Gating	of	CD150hi	and	CD150int	cells	within	the	LSK	CD48−	population.	(B)	Representative	plot	




Flt3,	 fms-like	 tyrosine	 kinase;	 M-CSFR,	 macrophage-colony	 stimulating	 factor;	 HSC,	
haematopoietic	stem	cell;	MPP,	multipotent	progenitor;	LSK,	Lineage	markers−	Sca1+	c-Kit+.	
Flt3- HSC Flt3+ HSC 










































(LSK	 CD150+	 CD48−)	were	 analysed	 according	 to	 high	 (CD150hi)	 or	 intermediate	 (CD150int)	
levels	of	CD150	expressed	on	 their	 surface.	Data	are	 the	mean	±	 standard	error	of	values	
obtained	 from	 n	 =	 6	mice,	 from	 2	 independent	 experiments.	 p	 values	 were	 obtained	 by	
performing	 two-tailed	 non-parametric	 student’s	 t-test	 where;	 **,	 p	 <	 0.01.	 HSC,	
haematopoietic	stem	cell;	LT,	long-term;	ST,	short-term;	Flt3,	fms-like	tyrosine	kinase	3;	M-





CD150int	 in	 comparison	 (Figure	 3.34).	 This	 difference	 was	 highly	 significant	 [p=0.0022],	
indicating	an	association	between	the	presence	of	Flt3	on	the	cell	surface	and	intermediate	
levels	of	CD150.	On	the	other	hand,	there	was	no	significant	difference	in	CD150	distribution	












haematopoietic	 stem	 cells	 and	multipotent	 progenitors	 and	
these	receptors	are	rarely	co-expressed	
	
Previous	 studies	 have	 provided	 evidence	 to	 suggest	 that	 HGF	 receptors	 are	 differentially	




320,	329].	However,	 it	 is	 largely	unclear	as	 to	 the	extent	 the	expression	of	HGF	 receptors	
changes	as	single	HSCs	exit	a	quiescent	state	and	begin	to	differentiate.	To	address	this,	the	
experiments	 outlined	 in	 this	 chapter	 utilised	 single	 cell	 gene	expression	 analysis	 and	 flow	
cytometry	to	investigate	the	expression	of	the	above	receptors	by	single	HSPCs	during	early	
haematopoiesis.	The	findings	presented	here	show	novel	patterns	of	Flt3,	M-CSFR	and	EpoR	
expression	 within	 the	 LT-HSC,	 ST-HSC	 and	 MPP	 compartments,	 and	 reveal	 that	 these	
receptors	are	differentially	regulated	during	multipotent	cell	maturation.	
	
The	 percentage	 of	 cells	 expressing	 Flt3,	 Epor,	 Csf1r	 mRNA	 within	 each	 analysed	 HSPC	
population	is	illustrated	using	the	pairwise	model	in	Figure	3.35,	while	the	percentage	of	cells	























a	 slight	 increase	 in	 FLT3	 and	 Flt3	 expression	 as	 LT-HSCs	 differentiate	 into	 ST-HSCs	 (FLT3,	
[p=0.3125];	Flt3,	[p=0.0022])	and	a	greater	increase	as	ST-HSCs	transition	to	the	MPP	stage	
(FLT3,	 [p=0.0313];	 Flt3,	 [p=0.0313]),	 supporting	 proposals	 that	 Flt3	 is	 upregulated	 at	 the	
expense	of	self-renewal	ability	[19,	20,	323].	Notably,	the	mean	levels	of	FLT3	expressed	by	
the	Flt3+	cells	within	these	compartments	were	not	different	(Figure	3.18A),	indicating	that	














compartment	 varied	 greatly	 when	 compared	 to	 the	 ST-HSC	 compartment,	 giving	 further	
indication	that	 regulation	of	 the	EPOR	gene	changes	during	 the	ST-HSC	to	MPP	transition.	
Previous	studies	have	also	shown	a	decrease	in	EPOR	expression	as	HSCs	mature	and	support	
the	findings	presented	here.	Lai	et	al.	have	reported	a	decrease	in	EPOR	expression	by	the	





















Figure	 3.35.	Mapping	 of	 FLT3,	CSF1R	 and	EPOR	gene	 expression	 to	 the	 pairwise	model.	
Values	shown	correspond	to	the	percentage	of	cells	within	the	given	HSPC	population	that	
were	found	to	express	FLT3,	CSF1R	and	EPOR.	The	legend	is	shown	in	the	top	right	corner.	For	
these	 experiments,	 HPC-1	 was	 isolated	 as	 LSK	 CD48+	 CD150−	 Flt3−/lo.	 LT-HSC,	 long-term	
haematopoietic	 stem	cell;	 ST-HSC	 short-term	haematopoietic	 stem	cell;	MPP,	multipotent	
progenitor;	HSPC,	haematopoietic	stem	and	progenitor	cell;	HPC,	haematopoietic	progenitor	
cell;	 LMPP,	 lymphoid-primed	multipotent	 progenitor;	 CLP,	 common	 lymphoid	 progenitor;	







HSCs	 and	 that	 these	 receptors	 are	 differentially	 regulated	 following	 transition	 of	 HSCs	 to	


















rarest	 cells	within	 this	 population	 (Figure	 3.32C),	 a	 high	 proportion	 of	M-CSFR+	MPPs	 co-
expressed	Flt3	(69.17%	±	3.29)	indicating	that	M-CSFR	expression	was	commonly	associated	




















lineage	commitment	occurs	within	 the	early	HSPC	compartments.	 For	example,	 long-term	
repopulating	cells	that	are	committed	to	mature	cell	fates	have	been	identified	within	the	LSK	
CD34–	population	of	 the	mouse	BM.	As	described	 in	Section	1.3.3,	 Yamamoto	et	al.	 have	




and	 MEP	 compartments	 using	 CD71	 and	 Mpl,	 the	 authors	 also	 reported	 that	 HSPC	
compartments	 are	 largely	 comprised	 of	 unilineage	 progenitors,	 rather	 than	 multilineage	














the	 DC,	 megakaryocyte,	 erythroid	 and	 GM	 lineages.	 Paul	 and	 co-workers	 have	 reported	
similar	 findings	by	analysing	RNA	sequencing	data	 from	2,730	single	 index	 sorted	myeloid	













shown	correspond	 to	 the	percentage	of	 cells	within	 the	given	HSPC	population	 that	were	
found	to	express	Flt3	and	M-CSFR	protein.	The	legend	is	shown	in	the	top	right	corner.	For	
these	 experiments,	 HPC-1	 was	 isolated	 as	 LSK	 CD48+	 CD150−	 Flt3−/lo.	 LT-HSC,	 long-term	
haematopoietic	 stem	cell;	 ST-HSC	 short-term	haematopoietic	 stem	cell;	MPP,	multipotent	
progenitor;	HSPC,	haematopoietic	stem	and	progenitor	cell;	HPC,	haematopoietic	progenitor	
cell;	 LMPP,	 lymphoid-primed	multipotent	 progenitor;	 CLP,	 common	 lymphoid	 progenitor;	






an	early	 stage	of	 their	maturation.	 Indeed,	MyHSCs	are	upstream	of	 LyHSCs	 [25,	26],	 and	




myeloid-related	 genes	 are	 enriched	 in	 the	 most	 primitive	 haematopoietic	 compartments	
prior	to	onset	of	lymphoid-associated	gene	expression.	In	2007,	Månsson	et	al.	used	multiplex	


















strongly	 correlated	 with	 a	 functional	 subpopulation	 of	 HSCs	 (Figure	 3.34).	 High	 levels	 of	
CD150	expression	on	the	surface	of	HSCs	are	associated	with	increased	self-renewal	capacity	







finding	 suggests	 that	 Flt3	 is	 upregulate	 upon	 transition	 of	 HSCs	 towards	 a	 GM-lymphoid	
primed	state	(See	section	3.7.2	for	further	discussion).	
	
Altogether,	 this	study	has	 identified	a	number	of	subpopulations	within	 the	HSC	and	MPP	
compartments	based	on	expression	of	Flt3,	M-CSFR	and	EPOR.	These	receptors	are	rarely	co-
expressed,	 and	 are	 differentially	 regulated	 as	 HSCs	 begin	 to	 mature,	 suggesting	 that	
expression	 of	 these	 receptors	 mark	 different	 stages	 of	 lineage	 priming	 during	 early	
haematopoiesis.	Isolation	and	characterisation	of	Flt3+,	M-CSFR+	and	Epor+	HSCs	will	help	to	
determine	 if	 there	 is	 a	 hierarchical	 relationship	 between	 these	 populations	 and	 provide	





compartment	 is	 associated	 with	 decreased	 self-renewal	
capacity	
	















LSK	 Flt3−	 cells	 into	 irradiated	hosts	 and	 compared	 the	multilineage	 reconstitution	of	 each	
population	[19].	The	authors	reported	that	LSK	Flt3+	failed	to	support	long-term	myelopoiesis,	
and	proposed	that	Flt3	was	upregulated	as	cells	 lost	self-renewal	ability	and	differentiated	






renewal	 potential.	More	 recently,	 Buza-Vidas	et	 al.	 have	used	FLT3-Cre:loxp-eYFP	mice	 to	
investigate	 if	 FLT3	 gene	 expression	 is	 initiated	 in	 self-renewing	 cells	 present	 in	 the	 HSC	
compartment	[323].	Again,	the	group	preformed	BM	transplantation	assays	and	monitored	










a	 rare	population	of	 self-renewing	Flt3+/Flt3+	cells	 [323].	Firstly,	 the	above	studies	did	not	
assess	the	ability	of	LSK	CD34−	Flt3+	cells	to	reconstitute	irradiated	hosts.	Additionally,	as	Buza-
Vidas	 et	 al.	 used	 the	 same	 number	 of	 LSK	 eYFP+	 and	 LSK	 EFYP−	 in	 their	 transplantation	























fates	 contain	 little	 to	 no	 cells	 that	 express	 EPOR.	 A	 similar	 pattern	 can	 be	 seen	 when	
considering	CSF1R	and	M-CSFR	expression.	 Interestingly,	expression	of	Flt3	protein	and	 its	
gene	followed	a	biphasic	pattern.	Only	a	small	number	of	cells	within	the	HSC	compartments	





3.35	 and	 Figure	 3.36	 are	 unremarkable.	 However,	 it	 is	 interesting	 that	 Flt3	 is	 primarily	
expressed	by	progenitors,	such	as	the	LMPP.	Flt3	is	strongly	associated	with	the	DC	lineage,	
so	it	is	likely	that	Flt3	marks	progenitors	with	DC	potential	(further	discussed	below).	These	










Csf1r+	 CMPs	 expressed	 levels	 that	were	 40-fold	 higher	 than	 other	Csf1r+	 CMPs.	 The	 data	








oligopotent	 HPC	 compartments	 contain	 a	 heterogeneous	 mixture	 of	 lineage	 committed	
progenitors,	 rather	 than	 a	 uniform	 population	 of	 oligopotent	 progenitors	 [24,	 304,	 332].	
Current	 evidence	 also	 suggests	 that	 a	 number	 of	 oligopotent	 haematopoietic	 progenitor	












is	 possible	 that	 EPOR	 expression	 within	 the	 CMP	 compartment	 marks	 EPs.	 If	 these	
subpopulations	identify	restricted	progenitors,	then	this	would	provide	further	evidence	to	
suggest	 that	 lineage	commitment	occurs	 in	early	HSPC	compartments,	 such	as	 the	HSC	or	
MPP	compartment	(see	Section	3.7.1	for	further	discussion).	Isolation	and	characterisation	
of	 the	 HPC	 subpopulations	 identified	 in	 this	 study	 will	 be	 required	 to	 confirm	 this.	















HemaExplorer	 and	 BloodSpot	 databases,	 FLT3	 expression	was	 the	 highest	 in	 the	 CLP	 and	
LMPP	populations.	It	was	also	expressed	by	LT-HSCs,	ST-HSCs,	LMPPs,	preGMs,	CLPs,	Pro-B-
lymphocytes	and	ETPs,	and	to	a	lesser	extent,	the	GMP	population	(Figure	3.1).	The	erythroid	
and	 megakaryocyte	 progenitors	 expressed	 levels	 of	 FLT3	 that	 suggested	 amplification	 of	
contaminating	gDNA,	indicating	that	these	cells	do	not	express	Flt3	mRNA.	A	similar	pattern	
was	seen	when	HSPCs	were	analysed	using	single	cell	qRT-PCR	analysis.	Both	the	LMPP	and	
CLP	 population	 contained	 a	 high	 number	 of	 Flt3+	 cells,	 reflecting	 the	 high	 levels	 of	 FLT3	
expression	observed	when	analysing	the	databases.	Flt3	was	also	regularly	detected	in	the	








extracted	 from	 the	 databases	 (Figure	 3.1),	 EPOR	 was	 highly	 expressed	 in	 the	 CFU-E,	 EP,	







































CHAPTER	4:			 INVESTIGATION	 OF	 FUNCTIONAL	





The	 studies	 undertaken	 in	Chapter	 3	 investigated	 the	 expression	 of	 the	 Flt3	 and	M-CSFR	
proteins,	and	the	FLT3,	EPOR	and	CSF1R	genes	by	HSPCs	to	determine	the	extent	to	which	
these	 receptors	 are	 heterogeneously	 expressed	within	HSPC	 compartments,	 and	whether	
early	HSPCs	co-express	these	receptors.	Expression	of	the	FLT3	and	EPOR	genes,	and	Flt3	and	
M-CSFR	 proteins,	 were	 detected	 in	 subpopulations	 within	 the	 LT-HSC,	 ST-HSC	 and	 MPP	
compartments.	Early	HSPCs	have	been	shown	to	respond	to	M-CSF	and	Epo	by	upregulating	






a	 dramatic	 expansion	 of	 myelomonocytic,	 granulocytic	 and	 lymphoid	 progenitors,	 and	 a	
decrease	in	the	number	of	MEPs	and	EPs	in	the	BM	[288].	Intraperitoneal	injection	of	Flt3L	
into	mice	resulted	in	a	rapid	reduction	of	EPs	and	MEPs,	and	the	kinetics	of	this	response	led	





















population,	 and	 the	 authors	 concluded	 that	 Flt3	was	 upregulated	 as	 stem	 cells	 began	 to	
mature.	In	later	studies,	both	the	Jacobsen	and	Weissman	groups	used	BM	transplantation	
assays	to	characterise	the	mouse	Flt3+	LSK	and	Flt3−	LSK	BM	populations,	and	reported	that	




































suggesting	 that	multipotent	 cells	express	Flt3.	 In	2006,	Forsberg	et	al.	observed	 that	Flt3+	
progenitors	 gave	 rise	 to	 very	 small	number	of	platelets	when	 transplanted	 into	 irradiated	
hosts,	albeit	with	lower	efficiency	than	Flt3−	cells	[341].	Shortly	after,	Lai	et	al.	divided	LSK	
Thy-1.1−	 Flt3+	 cells	 into	 Flt3hi	 and	 Flt3low	 fractions,	 and	 reported	 that	 Flt3low	 cells	 could	




































class	 III	 subfamily	 of	 receptor	 tyrosine	 kinases	 and	 plays	 a	 role	 in	 the	 regulation	 of	
haematopoietic	cell	survival,	proliferation	and	differentiation	[344-346].	The	receptor	has	an	
extracellular	 domain	 consisting	 of	 five	 immunoglobulin-like	 motifs,	 a	 single-pass	
transmembrane	domain,	 a	 juxtamembrane	domain,	 and	 two	 intracellular	 kinase	domains.	
When	inactive,	it	is	present	on	the	cell	membrane	as	a	monomeric	unphosphorylated	protein.	
Binding	 of	 Flt3L	 promotes	 dimerisation	 of	 the	 receptor	 and,	 subsequently,	












by	 the	 activation	 of	 STAT	 proteins,	 cyclic	 adenosine	 monophosphate	 response	 element-
binding	protein	and	Elk1	[353].		
	
Given	their	clinical	 relevance,	many	studies	have	 investigated	how	Flt3	containing	 internal	






following	 Flt3L	 stimulation	 [358].	 The	 authors	 found	 that	 Flt3-ITD	 signalling	 suppressed	
expression	of	SPI1	and	CEBPA,	while	WT	Flt3	signalling	stimulated	expression	of	these	genes.	
Similarly,	 sorted	 Lin−	 IL-7Rα−	 Thy1.1−	 c-Kit+	 Flt3−	 mouse	 BM	 cells	 which	 include	 MEPs,	
upregulate	 SPI1	 and	 CEBPA,	 and	 their	 dendritic	 cell	 potential	 greatly	 increases,	 when	
transfected	 with	 human	 Flt3	 [276].	 SPI1	 and	 CEBPA	 encode	 TFs	 that	 are	 associated	 with	













upstream	 of	 the	 LSK	 CD150−	 CD48+	 population.	 The	majority	 of	 LSK	 CD150−	 CD48−	MPPs	
express	high	levels	of	Flt3	(See	Figure	3.27	and	[34]),	so	it	is	possible	that	Flt3L	acts	on	this	
population	to	regulate	the	generation	of	GM-lymphoid	cells.	Furthermore,	Flt3	protein	was	











Flt3	 expression	 does	 mark	 a	 small	 subpopulation	 of	 HSCs	 within	 the	 LSK	 CD150+	 CD48−	
compartment	of	the	mouse	BM,	then	isolation	and	characterisation	of	this	population	will	be	
crucial	in	improving	our	understanding	of	how	Flt3	regulates	early	haematopoiesis.	Thus,	the	








of	 stimulation	 with	 Flt3L.	 This	 was	 carried	 out	 using	 flow	 cytometry	 to	 monitor	
phosphorylation	events	within	the	Flt3	signalling	pathway	in	single	cells	stimulated	with	Flt3L.	
Secondly,	 the	potential	 role	of	 Flt3	 in	HSPC	 transcriptional	 regulation	was	 investigated	by	












for	 experiments	 and	 measures	 the	 average	 expression	 of	 a	 target	 within	 a	 population.	








In	 order	 to	 stain	 for	 intracellular	 phosphorylated	 targets,	 cells	 need	 to	 be	 fixed	 and	














fixed	 using	 1.6%	 PFA	 (prepared	 in	 the	 lab)	 for	 15	 minutes	 at	 room	 temperature	 and,	


















Gr-1,	 TER-119,	 CD48,	 and	 CD34	 staining	 was	 unaffected.	 Acetone	 treatment	 preserved	
staining	 for	 all	 markers	 except	 CD150	 (Figure	 4.1).	 Interestingly,	 acetone	 treatment	 also	




complex	 to	 unconjugate,	 which	 prevented	 the	 use	 of	 the	 anti-CD48	 ACP-Cy7	 antibody	
together	with	the	anti-CD34	APC	antibody	when	performing	phosphoflow.	To	overcome	this,	
CD48	 expression	was	measured	 using	 a	 FITC	 conjugated	 antibody,	 and	 this	 antibody	was	































As	 before,	when	 the	 two	 samples	were	 compared,	 the	 CD150	 staining	 of	whole	 BM	was	
decreased	 in	 the	 fixed	 and	 permeabilised	 sample	 (Figure	 4.3C).	 Despite	 this,	 the	 CD150	
staining	was	bright	enough	to	distinguish	LT-HSC,	ST-HSC	and	MPP	populations	within	the	LSK	
compartment	in	the	treated	sample	(Figure	4.3B).	Furthermore,	all	populations	gated	in	the	


















Once	 the	 fixation	 and	 permeabilisation	 treatments	 for	 the	 protocol	 were	 chosen,	
downstream	 signalling	 proteins	 of	 the	 Flt3	 receptor	 were	 considered	 as	 a	 target	 for	
monitoring	 Flt3	 stimulation.	 Both	 the	 Ras	 and	 PI3K	 pathways	 converge	 by	 promoting	




















samples,	 CD150	 staining	was	 decreased	when	 comparing	 the	 expression	 of	 CD150	 by	 (C)	
whole	 bone	 marrow	 cells	 in	 the	 fixed/permeabilised	 sample	 (dotted	 black	 line)	 when	
compared	to	the	untreated	sample	(solid	black	line).	LT-HSC,	long-term	haematopoietic	stem	













serum-free	 IMDM	 immediately	 prior	 to	 Flt3L	 treatment.	 Cells	 were	 then	 stimulated	 with	
150ng/mL	Flt3L	before	being	fixed	with	1.6%	PFA	for	15	minutes	at	room	temperature	and	
permeabilised	using	ice-cold	acetone	for	15	minutes	at	-20°C.	Subsequently,	the	sample	was	
stained	 for	pS6.	A	 second,	unstimulated,	 cell	 suspension	was	prepared	as	a	 control	 in	 the	
same	manner.	In	agreement	with	the	findings	of	Kalaitzidis	and	Neel	[364],	analysis	revealed	








expressed	by	Flt3L	stimulated	cells	 (solid	black	 line)	compared	to	unstimulated	cells	 (black	



























starvation	period,	 the	 sample	was	 stimulated	with	150ng/mL	Flt3L	 for	7.5	minutes	before	
being	 fixed	 and	 permeabilised	 using	 1.6%	 paraformaldehyde	 and	 ice-cold	 acetone.	
Histograms	 show	 the	 level	 of	 pS6	 expressed	 by	 Flt3L	 stimulated	 MPPs	 (solid	 black	 line)	
compared	 to	 unstimulated	MPPs	 (black	 dotted	 line).	 There	 was	 no	 significant	 difference	
between	 the	 levels	 of	 pS6	 expressed	 by	 Flt3L	 stimulated	 MPPs	 and	 untreated	 controls,	
indicating	that	the	phosphoflow	protocol	was	working	intermittently	and,	thus,	not	reliable.	
















experiment	 had	 failed	 when	 analysing	MPPs.	 Regardless,	 this	 suggested	 that	 the	 current	
phosphoflow	 protocol	 was	 not	 reliable	 and	 could	 not	 be	 used	 to	 produce	 consistently	
reproducible	 data.	 As	 such,	 the	 protocol	 needed	 to	 be	 optimised	 further.	 For	 the	 initial	
phosphoflow	 experiments,	 cells	 were	 fixed	 using	 PFA	 that	 had	 been	 prepared	 in	 the	
laboratory.	To	determine	if	the	quality	of	the	PFA	prepared	in	the	laboratory	was	an	issue,	the	
experiment	 was	 repeated	 using	 commercial	 EM-grade	 PFA.	 Using	 the	 same	 protocol	 as	
before,	BM	cells	were	stained	using	the	HSPC	antibody	staining	panel,	stimulated	with	Flt3L,	





had	 been	 fixed	 using	 laboratory	 prepared	 PFA	 when	 compared	 to	 untreated	 controls.	
However,	 there	 was	 a	 large	 shift	 in	 the	 level	 of	 pS6	 in	 Flt3L	 stimulated	MPPs	 fixed	with	
commercial	EM-grade	PFA	(Figure	4.6).	This	indicated	that	the	quality	of	the	PFA	used	to	fix	
the	cells	during	the	phosphoflow	protocol	was	 important	 for	optimal	staining	of	phospho-























reproducible,	 pS6	 levels	 in	 MPPs	 were	 measured	 following	 fixation	 with;	 (A)	 laboratory	
prepared	PFA,	or	(B)	commercially	available	EM-grade	PFA.	Whole	bone	marrow	cells	were	




cold	 acetone	 and	 were	 subsequently	 stained	 for	 pS6	 before	 being	 analysed	 using	 flow	

























































































Culturing	 of	 HSCs	 in	 the	 presence	 of	 Flt3L	 did	 not	 result	 in	 an	 increase	 in	 the	 levels	 of	
intracellular	 pS6,	 indicating	 that	 cells	 within	 the	 LSK	 CD150+	 CD48−	 compartment	 do	 not	












































were	 detected	when	 the	 sequence	was	 analysed	 using	 the	BLAST	 genomic	 database.	 The	
assay	was	first	tested	using	reactions	with	and	without	the	RT	to	determine	if	the	assay	was	











the	 SPI1	 gene	 is	 depicted	 to	 show	 the	 alignment	 of	 the	 SPI1	qRT-PCR	 assay	 primers	 and	







Figure	 4.9.	 Optimisation	 of	 the	 SPI1	 qRT-PCR	 assay	 for	 detection	 of	 single	 cell	 gene	




multiple	 combinations	 of	 different	 primer	 concentrations	 (B)	 The	 Ct	 for	 all	 primer	
combinations	was	determined,	and	any	sample	with	a	Ct	value	of	>0.5	cycles	greater	than	the	
Ct	 value	 of	 the	 reference	 reaction	 (300nM	 forward	 primer/300nM	 reverse	 primer)	 was	
considered	to	have	low	efficiency	(below	the	transparent	grey	pane).	(C)	Of	the	remaining	

























































primer	 concentrations	 for	 the	 forward	and	 reverse	primers	were	 found	 to	be	300nM	and	
40nM,	 respectively	 (Figure	 4.9B,	 C).	 The	 optimum	 probe	 concentration	 was	 found	 to	 be	
175nM	(Figure	4.9D).	To	test	the	single	cell	sensitivity	of	the	SPI1	qRT-PCR	assay,	single	GMPs	
were	used,	as	these	cells	are	known	to	express	Spi1	transcripts	[369].	The	assay	successfully	







above	 paper,	 and	 the	 expression	 of	 SPI1	 by	 HSCs	 following	 incubation	 with	 Flt3L	 was	
investigated.	As	studies	to	date	have	only	shown	that	SPI1	is	a	direct	target	of	Flt3	signalling	
in	cells	that	ectopically	express	Flt3,	it	was	difficult	to	identify	an	endogenous	haematopoietic	
cell	 population	 that	 could	 be	 used	 as	 a	 positive	 control.	 Stimulation	 of	 CMPs	 with	 Flt3L	


















CMPs	and	MEPs	were	bulk	sorted	 from	whole	mouse	BM	 into	 IMDM	containing	10%	FCS,	
1,000 U/mL	penicillin	and	1,000 μg/mL	streptomycin,	50 ng/mL	Tpo	and	20 ng/mL	Scf,	with	
and	 without	 Flt3L.	 As	 150ng/mL	 of	 Flt3L	 produced	 a	 strong	 response	 in	 MPPs	 when	
monitoring	 pS6	 levels;	 the	 same	 concentration	 of	 Flt3L	 was	 used	 to	 investigate	 if	 Flt3	





















































of	 SPI1	 detected	 before	 35	 cycles	 was	 likely	 due	 to	 mRNA	 amplification	 and	 not	 gDNA	
amplification.	To	determine	if	Flt3L	stimulation	initiated	the	expression	of	Spi1	mRNA	in	cells,	




However,	 this	 change	 was	 not	 significant	 [p=0.4794].	 Similarly,	 there	 was	 no	 significant	
difference	 between	 the	 number	 of	 Flt3L	 treated	 ST-HSCs	 that	 expressed	 Spi1	mRNA	 (<35	
cycles,	65%)	and	when	compared	to	the	number	of	Spi1+	ST-HSCs	that	were	not	treated	with	
Flt3L	 (68%)	 [p=0.6224].	 Furthermore,	 there	was	no	 change	 in	Spi1	mRNA	expression	 (<35	
















curves	 represent	 amplification	 and	 green	 curves	 represent	 background	 fluorescence.	
Fluorescence	is	plotted	on	a	log	scale.	p	values	were	obtained	by	performing	(A)	two-tailed	
non-parametric	 student’s	 t-tests	 or	 (B)	 Fisher’s	 exact	 tests	 where;	 n.s.,	 p	 >	 0.05.	 HSC,	
haematopoietic	stem	cell;	LT,	long-term;	ST,	short-term;	CMP,	common	myeloid	progenitor;	





starved	 in	 serum-free	medium	 prior	 to	 stimulation	 with	 Flt3L	 to	minimise	 the	 activity	 of	
biological	 pathways.	 As	 this	 strategy	 worked	 well	 for	 the	 phosphoflow	 analysis,	 the	 SPI1	






















by	 first	 sorting	 cells	 into	 serum-free	 IMDM	 and	 starving	 them	 for	 3	 hours	 before	
supplementing	 the	 medium	 with	 10%	 FCS,	 1,000 U/mL	 penicillin	 and	 1,000 μg/mL	
streptomycin,	50 ng/mL	Tpo	and	20 ng/mL	Scf,	with	and	without	150ng/mL	Flt3L.	The	cells	










cells	after	the	18	hour	 incubation	period,	 it	was	clear	that	the	cells	were	 in	the	process	of	
dying	or	had	died	during	the	overnight	culture,	as	they	had	a	very	low	FSC	profile.	This	made	
it	difficult	to	discriminate	between	background	noise	and	cells.	The	FSC/SSC	gating	strategy	

































these	 experiments	 measured	 the	 response	 to	 Flt3L	 over	 short	 periods	 of	 exposure.	 By	
measuring	 downstream	 effects	 of	 Flt3	 signalling	 such	 as	 differentiation	 and	 survival	 after	
longer	 periods	 of	 treatment,	 the	 analysis	may	 benefit	 from	 an	 amplified	 response	 that	 is	
















stem	 cell;	 CFU,	 colony	 forming	 unit;	 M,	 macrophage;	 G,	 granulocyte;	 GM,	 granulocyte-





























CFU-GM	 [p>0.999],	 CFU-GEMM	 [p>0.999],	 CFU-Meg	 [p>0.999]	 or	 CFU-MegMix	 [p>0.999]	
(Figure	4.16A)	 (n=3	mice)	between	plates	with	and	without	Flt3L.	Similarly,	 there	were	no	
differences	in	colony	size	between	the	two	cultures.	These	findings	indicated	that	addition	of	











slides	 for	 staining	 with	 a	 Differential	 Quik	 stain	 kit.	 Macrophage/monocytes	 (M)	 were	










































	 Mouse	#1	 Mouse	#2	 Mouse	#3	 Mouse	#1	 Mouse	#2	 Mouse	#3	
Number	of	HSCs	
seeded/plate	 278	 335	 433	 278	 335	 433	
	 Plate	1	 Plate	2	 Plate	1	 Plate	2	 Plate	1	 Plate	2	 Plate	1	 Plate	2	 Plate	1	 Plate	2	 Plate	1	 Plate	2	
CFU-GEMM	 40	 40	 49	 60	 54	 49	 18	 26	 65	 47	 85	 104	
CFU-GM	 9	 13	 19	 12	 72	 53	 21	 18	 11	 28	 26	 18	
CFU-M	 8	 4	 8	 10	 19	 22	 8	 8	 8	 7	 23	 10	
CFU-G	 0	 2	 3	 2	 2	 6	 2	 4	 1	 4	 6	 2	
CFU-Meg	 5	 5	 13	 6	 16	 15	 8	 4	 10	 9	 9	 14	
CFU-Meg-Mix	 5	 3	 2	 2	 12	 6	 5	 3	 5	 1	 6	 6	
Total	 67	 67	 94	 92	 175	 151	 62	 63	 100	 96	 155	 154	
M3434	medium	allows	 for	 the	 formation	of	CFU-GEMM,	CFU-GM,	CFU-M,	CFU-G,	CFU-Meg,	CFU-Meg-Mix.	HSCs	were	 sorted	 from	
murine	bone	marrow	and	seeded	onto	M3434	and	incubated	at	37°C	5%	CO2	for	11	days.	On	day	11,	the	colony	type	was	determined	














cell	 fates	 [288].	However,	 the	data	generated	 in	Chapter	3	 revealed	 the	presence	of	FLT3	
transcripts	and	Flt3	protein	within	the	LSK	CD150+	CD48−	HSC	and	LSK	CD150−	CD48−	MPP	
compartments,	 suggesting	 that	 Flt3L	may	also	act	on	 these	 cells.	Hence,	 the	 focus	of	 this	












in	 either	 the	 LT-HSC	or	 ST-HSC	 compartments	 following	 culture	with	 Flt3L,	 and	 the	mean	












of	 the	 CD150	 antigen	 is	 compromised	 when	 analysing	 whole	 BM	 cells	 after	 acetone	
treatment,	 CD150	 can	 still	 be	 used	 to	 successfully	 distinguish	 HSCs	 from	MPPs	 using	 the	
phosphoflow	protocol	described	here	(Figure	4.3).		
	





differentiation,	such	as	SPI1,	CEBPA	or	 IKZF1	 [125,	359,	360,	370].	 Indeed,	upregulation	of	
















this	 is	 unlikely,	 as	 dead	 cells	 can	 be	 identified	 by	 their	 FSC/SSC	 profile	 (Figure	 4.13).	
Furthermore,	while	the	culture	conditions	used	are	adequate	for	HSC	culture	[267],	they	may	
not	have	been	adequate	for	the	culture	of	CMPs.	For	example,	IL-3	was	not	included	in	the	
























In	 addition	 to	monitoring	 the	molecular	 changes	of	HSCs	 following	 culture	with	Flt3L,	 the	
cellular	response	of	HSCs	to	Flt3L	was	also	investigated.	If	a	fraction	of	LSK	CD150+	CD48−	cells	
expressed	 functional	 Flt3,	 stimulation	 of	 the	 receptor	 may	 improve	 their	 survival	 [352].	
Additionally,	 if	 Flt3L	 is	 indeed	 instructive,	 any	 Flt3+	 HSCs	 would	 be	 driven	 away	 from	




forming	 potential	 of	 HSC-1	 (LSK	 CD150+	 CD48−	 CD229−/low)	 and	 HSC-2	 (LSK	 CD150+	 CD48−	
CD229+)	[34].	Comparison	of	the	colony	forming	potential	of	HSCs	in	M3434	with	and	without	
25ng/mL	Flt3	revealed	no	change	 in	the	numbers	of	CFU-M,	CFU-G,	CFU-GM,	CFU-GEMM,	
CFU-Meg	or	CFU-MegMix.	Additionally,	 the	 total	number	of	 colonies	 in	both	 samples	was	
similar.	 Together,	 these	 indicate	 that	 the	 presence	 of	 25ng/mL	 Flt3L	 did	 not	 alter	 the	
contribution	 of	 HSCs	 to	 particular	 lineages	 or	 confer	 a	 survival	 advantage	 to	HSCs	 during	
colony	formation.		
	







analysis	 of	 the	 phosphoflow	 experiments,	 an	 average	 response	 within	 the	 whole	 HSC	
population	was	calculated.	This	analysis	may	have	neglected	any	changes	that	occurred	at	the	
single	cell	level.	Ideally,	the	response	of	cells	to	Flt3L	would	be	presented	as	a	percentage	of	









The	 concentration	 of	 Flt3L	 used	 for	 the	 colony	 forming	 assays	 was	 lower	 than	 the	
concentration	used	in	the	phosphoflow	assays,	so	the	results	from	the	colony	forming	assay	
do	not	preclude	the	possibility	that	higher	amounts	of	Flt3L	are	required	to	elicit	a	response	

















be	 redundant	 in	 HSCs	 [340].	 A	 combination	 of	 the	 factors	 highlighted	 above	 may	 have	
hindered	the	detection	of	any	HSC	response	during	the	experiments	carried	in	this	chapter.	
Altogether,	 it	 is	 clear	 from	 the	 findings	 presented	 here	 that	 the	 LSK	 CD150−	 CD48−	MPP	
compartment	 responds	 to	 Flt3L,	 but	 the	 presence	 of	 functional	 Flt3	 within	 the	 HSC	
compartment	remains	uncertain.	
	
4.5.2			A	 role	 for	 Flt3L	 in	 the	 regulation	 of	 multipotent	
progenitors	during	steady-state	haematopoiesis	
	
Tsapogas	 et	 al.	 observed	 the	 expansion	 of	 BM	 DCs	 and	 a	 rapid	 decrease	 in	 BM	 MegE	
progenitors	following	administration	of	Flt3L	to	WT	mice,	and	suggested	that	Flt3L	may	drive	
an	upstream	progenitor	 towards	a	GM-lymphoid	 fate	at	 the	expense	of	MegE	production	
[288].	As	there	was	a	significant	expansion	of	LSK	CD150−	CD48+	cells	in	Flt3-Tg	mice	when	
compared	to	wild	type	controls,	the	Rolink	group	largely	attributed	the	Flt3L	response	to	this	
population.	 However,	 the	 LSK	 CD150−	CD48+	 compartment	 contains	GM-lymphoid	 primed	









LSK	 CD150−	 CD48+	 progenitors	 [34],	 so	 the	 response	 of	 these	 populations	 to	 Flt3L	 was	

















a	 temporarily	 inducible	 hyperactive	 ‘Sleeping	 Beauty’	 transposase	 mouse	 model	 [383].	
Doxycycline	 induction	 of	 the	 hyperactive	 Sleeping	 Beauty	 transposase	 results	 in	 the	
mobilisation	 of	 a	 specific	 transposon	 within	 the	 genome.	 Due	 to	 the	 variable	 nature	 of	
transposon	 insertion,	 individual	 cells	 and	 its	progeny	 could	be	 identified	based	on	unique	




haematopoietic	 cells	 at	 a	 number	 of	 time	 points	 after	 hyperactive	 Sleeping	 Beauty	








progenitors	 [24,	 304,	 332].	 LSK	 CD150−	 CD48−	 MPPs	 robustly	 reconstitute	 platelets	 and	
erythroid	cells	in	vivo	[22,	34].	However,	this	compartment	can	be	divided	into	Flt3−	and	Flt3+	
fractions,	 and	 studies	 have	 yet	 to	 characterise	 these	 two	 populations	 to	 determine	 their	




























the	role	of	HGFs	 in	 the	 lineage	commitment	of	HSPCs.	Some	studies	support	a	permissive	
action	of	HGFs,	whereby	these	factors	provide	proliferative	and	survival	cues	to	permit	the	











become	 granulocytes	 and	 macrophages,	 respectively	 [268].	 As	 both	 cell	 death	 and	
differentiation	 were	monitored	 at	 the	 single	 cell	 level,	 the	 data	 firmly	 argue	 against	 the	








































a	 varying	 degree	 in	 almost	 all	 HSPC	 compartments	 (Figure	 3.17	 and	 Figure	 3.27).	 The	





maturity.	 Notably,	 multiplex	 analysis	 revealed	 that	 co-expression	 of	 these	 receptors	 is	
uncommon	within	the	multipotent	compartments,	though	co-expression	of	M-CSFR	and	Flt3	




observed	 within	 the	 LSK	 CD150−	 CD48−	 MPP	 compartment	 following	 stimulation	 of	 Flt3,	
suggesting	that	Flt3L	predominantly	acts	further	upstream	than	M-CSF	and	Epo	(Figure	4.7).	
However,	 this	 study	 may	 underestimate	 the	 number	 of	 Flt3+	 cells	 within	 the	 HSC	
compartment.	 The	 techniques	 used	 in	 this	 study	may	 not	 have	 been	 sensitive	 enough	 to	
identify	HSCs	that	express	very	few	Flt3	proteins	on	their	surface	(further	discussed	below).	
	








were	 shown	 to	 stimulate	 bipotent	 GMPs	 to	 differentiate	 towards	 macrophage	 and	
granulocyte	fates,	respectively.	By	tracking	cell	death	using	real-time	imaging,	Rieger	et	al.	
demonstrated	that	this	response	was	not	due	to	the	selective	expansion	of	distinct	unilineage	






















important	 for	 the	 development	 of	 myelomonocytic	 cells,	 while	 Flt3	 and	 EpoR	 signalling	










certain	 HGFs	 have	 been	 shown	 to	 differentially	 regulate	 distinct	 lineage-biased	 HSC	






term	 repopulating	 CMRPs,	 MkRPs	 and	 MERPs	 [23,	 24].	 Other	 studies	 have	 shown	 that	
currently	defined	HPCs	are	heterogeneous	populations	containing	a	mixture	of	unilineage	and	
bipotent	 progenitors,	 indicating	 that	 lineage	 commitment	 occurs	 upstream	 of	 the	 HPC	
compartments.	 [24,	 304,	 332].	 For	 example,	 Paul	et	 al.	 have	 demonstrated	 that	 the	CMP	
compartment	 of	 the	 mouse	 BM	 contains	 at	 least	 19	 transcriptionally	 distinct	 progenitor	





































distinct	 lineage-restricted	 and/or	 lineage-biased	 subpopulations.	 The	 isolation	 and	
characterisation	of	the	lineage	potentials	of	these	cell	fractions	will	be	required	to	confirm	








an	 underestimate	 of	 the	 number	 of	 Flt3+	 and	 M-CSFR+	 cells	 within	 the	 HSC	 and	 MPP	








is	 also	 possible	 that	 co-expression	 of	 other	 HGF	 receptors	 is	 commonplace	 during	
haematopoiesis.	As	highlighted	above,	 there	 is	evidence	 to	 suggest	 that	HSPCs	co-express	







reported	 that	 M-CSF	 is	 capable	 of	 upregulating	 PU.1	 in	 a	 large	 number	 of	 these	 cells.	
Transplantation	of	M-CSF-stimulated	PU.1+	HSCs	into	irradiated	hosts	revealed	that,	although	
these	 cells	 were	 multipotent,	 their	 development	 was	 skewed	 towards	 the	 GM	 lineage.	
However,	after	6	weeks,	this	bias	had	disappeared	and	the	contribution	of	these	cells	to	other	
lineages	had	become	comparable	to	the	lineage-output	of	unstimulated	HSCs.	These	findings	






HSPCs	 [267,	269,	288].	This	 suggests	 that	 signalling	below	a	certain	 threshold,	due	 to	 low	
growth	 factor	 availability	 or	 a	 low	 level	 of	 receptor	 expression,	 does	not	mediate	 lineage	
instruction.	There	 is	also	evidence	 to	suggest	 that	HGFs	 regulate	 lineage-specification	 in	a	
dose-dependent	manner.	Metcalf	has	reported	that	low	concentrations	of	GM-CSF	promote	





there	 is	 a	 relationship	 between	 the	 levels	 of	 Gata-1	 expressed	 by	 a	 cell	 and	 its	 lineage	
potential	[386].	For	example,	the	group	ectopically	expressed	GATA-1	in	a	macrophage	cell	
line	and	demonstrated	that	these	cells	were	transformed	into	three	distinct	cell	types.	Low	
levels	 of	 GATA-1	 expression	 were	 shown	 to	 transform	 these	 cells	 into	 myeloblasts,	
intermediate	 levels	 induced	 an	 eosinophilic	 fate	 and	 high	 expression	 levels	 of	 GATA-1	
promoted	 their	 transformation	 into	 erythroblasts.	 As	 Epo	 has	 been	 shown	 to	 induce	






authors	 reported	 that	 MafB−/−	 LSK	 cells	 proliferate	 at	 a	 much	 higher	 rate	 and	 produce	
significantly	more	GM	cells	in	response	to	M-CSFR	stimulation	when	compared	to	WT	HSCs.	
Ectopic	expression	of	MafB	in	an	M-CSFR-transduced	T-lymphocyte	cell	line	prevented	these	
cells	 from	 proliferating	 in	 the	 presence	 of	 M-CSF.	 However,	 their	 response	 to	 IL-7	 was	
unaffected.	Furthermore,	using	a	PU.1:GFP	reporter	model,	it	was	shown	that	an	increased	
number	of	MafB−/−	LSK	Flt3−	cells	upregulated	PU.1	in	the	presence	of	M-CSF	when	compared	
to	WT	cells.	Oburoglu	et	al.	have	also	 shown	that	Epo-mediated	erythroid	 specification	 in	
CD34+CD38−	hHSCs	is	sensitive	to	the	availability	of	cell	metabolites	[289].	The	group	reported	


















To	 further	 explore	 how	 HGFs	 regulate	 lineage	 commitment	 during	 haematopoiesis,	 the	
factors	that	control	the	expression	of	their	receptors	will	need	to	be	determined.	There	 is	
evidence	 to	 suggest	 that	 some	HGF	 receptors	 are	upregulated	 following	 the	 activation	of	
other	 growth	 factor	 receptor	 signalling	 cascades.	 IL-1	 has	 been	 shown	 to	 stimulate	 the	




the	 requirements	of	 the	host.	Chen	et	al.	have	 reported	 that	 type	 I	 interferon,	a	cytokine	
produced	during	infection	[390],	stimulates	the	upregulation	of	Flt3	on	the	surface	CLPs	[373].	
A	number	of	studies	have	also	demonstrated	that	EpoR	expression	 is	regulated	by	oxygen	










et	 al.	 have	 demonstrated	 that	 transcriptional	 noise	 can	 mediate	 the	 transition	 of	 HSPC	























There	 is	still	more	work	to	be	done	to	truly	 identify	the	mechanisms	that	regulate	 lineage	
commitment	during	haematopoiesis.	However,	 this	 study	has	provided	an	 insight	 into	 the	
expression	 patterns	 of	 HGF	 receptors	 by	 HSPCs	 and	 has	 revealed	 several	 novel	 findings.	
Firstly,	 the	observation	that	early	HSPCs	rarely	co-express	Flt3,	M-CSFR	and/or	EPOR	adds	
further	complexity	to	the	debate	regarding	the	role	of	HGFs	 in	the	 lineage-specification	of	
HSPCs.	 It	appears	 that	 simply	defining	 lineage	specification	using	either	a	deterministic	or	
selective	model	of	haematopoiesis	is	impractical;	the	findings	from	this	study,	taken	together	
























do	 recipients	 receive	 a	 long-term	 granulocyte-biased	 transplant?	 As	 infection	 is	 a	 severe	
complication	of	BM	transplantation	[397],	an	increased	production	in	granulocytes	following	
the	procedure	would	be	favoured	as	to	avoid	post-transplantation	infections.	However,	this	






regulated	 and,	 as	 highlighted	 above,	 how	 the	 intrinsic	 state	of	 target	 cells	 affects	 lineage	
instruction.	Specifically,	 the	 isolation	and	characterisation	of	distinct	HSPC	subpopulations	
based	on	the	expression	of	HGF	receptors	will	be	important	to	investigate	the	mechanism(s)	





expression	 of	 HGF	 receptors	 by	 HSPCs,	 a	 lot	 more	 work	 is	 required	 to	 understand	 the	





Flt3+,	 M-CSFR+	 and	 EPOR+	 cells	 within	 each	 BM	 compartment	 should	 be	 isolated	 and	
characterised.	 It	 will	 be	 of	 interest	 to	 perform	 in	 vitro	 colony	 forming	 assays	 and	 in	 vivo	
reconstitution	assays	to	determine	the	lineage	potential	and	self-renewal	capacity	of	these	
cells.	Additional	analysis,	such	as	the	use	of	single	cell	gene	expression	assays,	will	help	to	
identify	 the	 functional	and	 transcriptional	properties	of	 these	cells.	These	approaches	will	





















































































Specificity	 Isotype	 Clone	 Source	 Conjugate	 Dilution	
Lin	Cocktail	 -	 -	 eBiosciences	 FITC	 1/10	
CD3	 Rat	IgG2b,	κ	 17A2	 BioLegend	 AF488	 1/100	
CD11b	 Rat	IgG2b,	κ	 M1/70	 BioLegend	 AF488	 1/200	
B220/CD45R	 Rat	IgG2a,	κ	 RA3-6B2	 BioLegend	 AF488	 1/100	
TER-119	 Rat	IgG2b,	κ	 TER-119	 BioLegend	 AF488	 1/400	
Gr-1	 Rat	IgG2b,	κ	 RB6-8C5	 BioLegend	 AF488	 1/200	
CD11b	 Rat	IgG2b,	κ	 M1/70	 BioLegend	 AF488	 1/200	
CD48	 Ar	Ham	IgG1	 HM48-1	 BioLegend	 AF488	 1/200	
CD71	 Rat	IgG2a,	λ	 R17217	 eBiosciences	 PE	 1/200	
CD16/32	 Rat	IgG2a,	λ	 93	 BioLegend	 PE	 1/200	
CD150	 Rat	IgG2a,	λ	 TC15-12F12.2	 BD	Biosciences	 PE	 1/50	
IL-7Rα	(CD127)	 Rat	IgG2a,	κ	 A7R34	 eBiosciences	 PE	 1/50	
Flt3	(CD135)	 Rat	IgG2a,	κ	 A2F10	 eBiosciences	 PE	 1/100	
pS6	 Rb	IgG	 D57.2.2E	 Cell	Signalling	 PE	 1/50	
Flt3	(CD135)	 Rat	IgG2a,	κ	 A2F10.1	 BD	Biosciences	 PE-CF594	 1/200	
c-Kit	(CD117)	 Rat	IgG2b,	κ	 2B8	 BD	Biosciences	 PE-CF594	 1/400	
Sca1	(Ly-6a)	 Rat	IgG2a,	κ	 D7	 eBiosciences	 PE-Cy5	 1/100	
IL-7Rα	(CD127)	 Rat	IgG2a,	κ	 A7R34	 BioLegend	 PE-Cy5	 1/200	
CD150	 Rat	IgG2a,	λ	 TC15-12F12.2	 BioLegend	 PE-Cy5	 1/100	
Sca1	(Ly-6a)	 Rat	IgG2a,	κ	 D7	 eBiosciences	 PCP-Cy5.5	 1/100	
CD48	 Ar	Ham	IgG	 HM48-1	 BD	Biosciences	 PE-Cy7	 1/200	
Sca1	(Ly-6a)	 Rat	IgG2a,	κ	 D7	 eBiosciences	 PE-Cy7	 1/100	
IL-7Rα	(CD127)	 Rat	IgG2a,	κ	 A7R34	 eBiosciences	 PE-Cy7	 1/50	
CD115	 Rat	IgG2a,	κ	 AFS98	 BD	Biosciences	 BV421	 1/200	
CD16/32	 Rat	IgG2a,	λ	 93	 BioLegend	 BV421	 1/200	
CD150	 Rat	IgG2a,	λ	 TC15-12F12.2	 BioLegend	 PB	 1/50	
IL-3R	(CD123)	 Rat	IgG2a,	κ	 5B11	 eBiosciences	 APC	 1/50	
Sca1	(Ly-6a)	 Rat	IgG2a,	κ	 D7	 eBiosciences	 APC	 1/100	
CD34	 Rat	IgG2a,	λ	 RAM34	 eBiosciences	 eFluor	
660	
1/50	
CD48	 Ar	Ham	IgG1	 HM48-1	 BioLegend	 APC-Cy7	 1/200	
CD114	 Rat	IgG2A	 723806	 R&D	Systems	 Purified	 -	
Lin,	lineage;	Ar	Ham,	Armenian	hamster;	AF488,	alexa	fluor	488;	pS6,	phospho-S6	ribosomal	
protein;	PB,	pacific	blue;	IL-7R,	interleukin-7	receptor	α	subunit;	IL-3R,	interleukin-3	
receptor;	Flt3,	fms-like	tyrosine	kinease	3;	APC,	allophycocyanin.	
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